<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.08.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="9" family="Times New Roman" color="#000000"/>
	<fontspec id="1" size="14" family="Times New Roman" color="#000000"/>
	<fontspec id="2" size="20" family="Times New Roman" color="#000000"/>
	<fontspec id="3" size="10" family="Times New Roman" color="#000000"/>
	<fontspec id="4" size="20" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="5" size="1" family="Times New Roman" color="#000000"/>
	<fontspec id="6" size="12" family="ABCDEE+Barcode 3 of 9 by request,BoldItalic" color="#000000"/>
	<fontspec id="7" size="10" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="8" size="5" family="Times New Roman" color="#000000"/>
	<fontspec id="9" size="14" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="10" size="12" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="11" size="3" family="Times New Roman" color="#000000"/>
	<fontspec id="12" size="9" family="Times New Roman" color="#0000ff"/>
<text top="51" left="60" width="2" height="8" font="0"> </text>
<text top="45" left="123" width="87" height="16" font="1">United Nations </text>
<text top="51" left="217" width="2" height="8" font="0"> </text>
<text top="38" left="508" width="15" height="22" font="2">A</text>
<text top="47" left="523" width="35" height="11" font="3">/72/137 </text>
<text top="112" left="63" width="2" height="8" font="0"> </text>
<text top="112" left="121" width="2" height="8" font="0"> </text>
<text top="68" left="123" width="153" height="22" font="4"><b>General Assembly </b></text>
<text top="73" left="385" width="2" height="8" font="0"> </text>
<text top="77" left="397" width="66" height="11" font="3">Distr.: General </text>
<text top="90" left="397" width="58" height="11" font="3">14 July 2017 </text>
<text top="104" left="397" width="2" height="9" font="3"> </text>
<text top="114" left="397" width="77" height="11" font="3">Original: English </text>
<text top="211" left="60" width="0" height="1" font="5"> </text>
<text top="738" left="60" width="114" height="11" font="3">17-11954 (E)    240817     </text>
<text top="749" left="60" width="113" height="17" font="6"><i><b>*1711954* </b></i></text>
<text top="750" left="491" width="2" height="9" font="3"> </text>
<text top="759" left="60" width="2" height="9" font="3"> </text>
<text top="213" left="60" width="107" height="11" font="7"><b>Seventy-second session </b></text>
<text top="225" left="60" width="169" height="11" font="3">Item 73 (b) of the provisional agenda* </text>
<text top="237" left="60" width="264" height="11" font="7"><b>Promotion and protection of human rights: human rights </b></text>
<text top="249" left="60" width="284" height="11" font="7"><b>questions, including alternative approaches for improving the </b></text>
<text top="261" left="60" width="191" height="11" font="7"><b>effective enjoyment of human rights and  </b></text>
<text top="273" left="60" width="106" height="11" font="7"><b>fundamental freedoms </b></text>
<text top="286" left="123" width="1" height="5" font="8"> </text>
<text top="292" left="123" width="1" height="5" font="8"> </text>
<text top="298" left="123" width="1" height="5" font="8"> </text>
<text top="305" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="305" left="111" width="377" height="13" font="9"><b>  Right of everyone to the enjoyment of the highest attainable </b></text>
<text top="317" left="123" width="240" height="16" font="9"><b>standard of physical and mental health </b></text>
<text top="334" left="123" width="1" height="5" font="8"> </text>
<text top="340" left="123" width="1" height="5" font="8"> </text>
<text top="347" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="347" left="111" width="182" height="11" font="10"><b>  Note by the Secretary-General </b></text>
<text top="359" left="123" width="1" height="5" font="8"> </text>
<text top="365" left="123" width="1" height="5" font="8"> </text>
<text top="373" left="123" width="2" height="9" font="3"> </text>
<text top="371" left="147" width="343" height="11" font="3">The Secretary-General has the honour to transmit to the General Assembly the </text>
<text top="383" left="123" width="367" height="11" font="3">report  of  the  Special  Rapporteur  on  the  right  of  everyone  to  the  enjoyment  of  the </text>
<text top="395" left="123" width="367" height="11" font="3">highest attainable standard of physical and  mental health, Dainius Puras, submitted </text>
<text top="407" left="123" width="301" height="11" font="3">in accordance with Human Rights Council resolutions 6/29 and 24/6. </text>
<text top="427" left="123" width="2" height="9" font="3"> </text>
<text top="445" left="123" width="2" height="9" font="3"> </text>
<text top="463" left="123" width="2" height="9" font="3"> </text>
<text top="463" left="267" width="2" height="9" font="3"> </text>
<text top="714" left="60" width="1" height="5" font="8"> </text>
<text top="719" left="60" width="1" height="3" font="11"> </text>
<text top="724" left="95" width="2" height="8" font="0"> </text>
<text top="723" left="116" width="7" height="9" font="0">*<a href="https://undocs.org/A/72/150"> </a></text>
<text top="723" left="124" width="34" height="9" font="12"><a href="https://undocs.org/A/72/150">A/72/150</a></text>
<text top="723" left="158" width="5" height="9" font="0"><a href="https://undocs.org/A/72/150">. </a></text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="13" size="9" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="14" size="7" family="Times New Roman" color="#000000"/>
	<fontspec id="15" size="12" family="Times New Roman,Italic" color="#000000"/>
	<fontspec id="16" size="7" family="Times New Roman,Italic" color="#000000"/>
	<fontspec id="17" size="10" family="Arial" color="#000000"/>
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="18" height="8" font="13"><b>2/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="72" left="123" width="369" height="16" font="9"><b>Report of the Special Rapporteur on the right of everyone to </b></text>
<text top="87" left="123" width="365" height="16" font="9"><b>the enjoyment of the highest attainable standard of physical </b></text>
<text top="102" left="123" width="113" height="16" font="9"><b>and mental health </b></text>
<text top="119" left="123" width="1" height="5" font="8"> </text>
<text top="125" left="123" width="1" height="5" font="8"> </text>
<text top="131" left="123" width="1" height="5" font="8"> </text>
<text top="149" left="60" width="63" height="11" font="15"><i>  Summary </i></text>
<text top="169" left="123" width="2" height="9" font="3"> </text>
<text top="166" left="147" width="347" height="11" font="3">Corruption can  have  a devastating  effect  on  good  governance,  the rule  of law, </text>
<text top="178" left="123" width="371" height="11" font="3">development and the equitable enjoyment of all human rights, including the right to </text>
<text top="190" left="123" width="372" height="11" font="3">health. In many countries health care is among the most corrupt sectors,  threatening </text>
<text top="202" left="123" width="371" height="11" font="3">the  sustainability  of  health-care  systems  worldwide.  Corruption  originates  from </text>
<text top="214" left="123" width="369" height="11" font="3">power  imbalances  and  asymmetries,  is  perpetuated  by  non-transparent  decision-</text>
<text top="226" left="123" width="371" height="11" font="3">making  and  reinforces  ineffective  and  harmful  policymaking  and  health  services </text>
<text top="238" left="123" width="371" height="11" font="3">provision.  The  present  report  is  focused  not  only  on  those  forms  of  corruption  that </text>
<text top="250" left="123" width="371" height="11" font="3">are legally defined as breaking the law and should be brought to justice, but also on </text>
<text top="262" left="123" width="371" height="11" font="3">those  practices  which  undermine  principles  of  medical  ethics  and  social  justice,  as </text>
<text top="274" left="123" width="371" height="11" font="3">well as effective and transparent health-care provision. The right to health provides a </text>
<text top="286" left="123" width="371" height="11" font="3">valuable  normative  framework  and  constitutes  a  legally  binding  imperative  to </text>
<text top="298" left="123" width="371" height="11" font="3">analyse  and  address  corruption  affecting  the  right  to  health  and  occurring  in  and </text>
<text top="310" left="123" width="110" height="11" font="3">beyond the health sector. </text>
<text top="331" left="123" width="2" height="9" font="3"> </text>
<text top="347" left="123" width="1" height="5" font="8"> </text>
<text top="353" left="123" width="1" height="5" font="8"> </text>
<text top="359" left="123" width="1" height="5" font="8"> </text>
<text top="364" left="60" width="50" height="16" font="1">Contents</text>
<text top="366" left="110" width="4" height="13" font="9"><b> </b></text>
<text top="387" left="113" width="2" height="6" font="16"><i>  </i></text>
<text top="387" left="529" width="2" height="6" font="16"><i> </i></text>
<text top="385" left="540" width="17" height="8" font="16"><i>Page </i></text>
<text top="402" left="108" width="70" height="9" font="3">I.  Introduction</text>
<text top="403" left="178" width="350" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="402" left="528" width="2" height="9" font="3"> </text>
<text top="400" left="550" width="8" height="11" font="3">3 </text>
<text top="420" left="104" width="262" height="9" font="3">II.  Corruption and the right to health: key issues and trends</text>
<text top="421" left="367" width="162" height="8" font="0">  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="420" left="528" width="2" height="9" font="3"> </text>
<text top="418" left="550" width="8" height="11" font="3">4 </text>
<text top="438" left="100" width="292" height="9" font="3">III.  Corruption and the normative framework of the right to health</text>
<text top="439" left="394" width="135" height="8" font="0">  . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="438" left="528" width="2" height="9" font="3"> </text>
<text top="436" left="550" width="8" height="11" font="3">8 </text>
<text top="456" left="125" width="10" height="9" font="3">A.</text>
<text top="456" left="135" width="3" height="9" font="17"> </text>
<text top="454" left="146" width="213" height="11" font="3">The right to health as a legally binding obligation</text>
<text top="457" left="360" width="168" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="456" left="528" width="2" height="9" font="3"> </text>
<text top="454" left="550" width="8" height="11" font="3">8 </text>
<text top="474" left="125" width="9" height="9" font="3">B.</text>
<text top="474" left="135" width="3" height="9" font="17"> </text>
<text top="472" left="146" width="267" height="11" font="3">Available, accessible, acceptable and good-quality health care</text>
<text top="475" left="414" width="115" height="8" font="0">  . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="474" left="528" width="2" height="9" font="3"> </text>
<text top="472" left="545" width="13" height="11" font="3">10 </text>
<text top="492" left="125" width="9" height="9" font="3">C.</text>
<text top="492" left="135" width="3" height="9" font="17"> </text>
<text top="490" left="146" width="244" height="11" font="3">Underlying and social determinants of the right to health</text>
<text top="493" left="391" width="137" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="492" left="528" width="2" height="9" font="3"> </text>
<text top="490" left="545" width="13" height="11" font="3">11 </text>
<text top="510" left="125" width="10" height="9" font="3">D.</text>
<text top="510" left="135" width="3" height="9" font="17"> </text>
<text top="508" left="146" width="197" height="11" font="3">Participation, transparency and accountability</text>
<text top="511" left="344" width="184" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="510" left="528" width="2" height="9" font="3"> </text>
<text top="508" left="545" width="13" height="11" font="3">12 </text>
<text top="528" left="125" width="9" height="9" font="3">E.</text>
<text top="528" left="134" width="3" height="9" font="17"> </text>
<text top="526" left="146" width="189" height="11" font="3">Role and responsibilities of non-state actors</text>
<text top="529" left="336" width="193" height="8" font="0">  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="528" left="528" width="2" height="9" font="3"> </text>
<text top="526" left="545" width="13" height="11" font="3">15 </text>
<text top="546" left="100" width="264" height="9" font="3">IV.  Issue in focus: corruption and the right to mental health</text>
<text top="547" left="365" width="164" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="546" left="528" width="2" height="9" font="3"> </text>
<text top="544" left="545" width="13" height="11" font="3">16 </text>
<text top="564" left="104" width="171" height="9" font="3">V.  Conclusions and recommendations</text>
<text top="565" left="275" width="253" height="8" font="0">  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="564" left="528" width="2" height="9" font="3"> </text>
<text top="562" left="545" width="13" height="11" font="3">20 </text>
<text top="582" left="125" width="10" height="9" font="3">A.</text>
<text top="582" left="135" width="3" height="9" font="17"> </text>
<text top="580" left="146" width="53" height="11" font="3">Conclusions</text>
<text top="583" left="200" width="329" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="582" left="528" width="2" height="9" font="3"> </text>
<text top="580" left="545" width="13" height="11" font="3">20 </text>
<text top="600" left="125" width="9" height="9" font="3">B.</text>
<text top="600" left="135" width="3" height="9" font="17"> </text>
<text top="598" left="146" width="79" height="11" font="3">Recommendations</text>
<text top="601" left="226" width="302" height="8" font="0"> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  </text>
<text top="600" left="528" width="2" height="9" font="3"> </text>
<text top="598" left="545" width="13" height="11" font="3">20 </text>
<text top="618" left="60" width="2" height="9" font="3"> </text>
<text top="630" left="60" width="2" height="9" font="3"> </text>
<text top="648" left="123" width="2" height="9" font="3"> </text>
<text top="648" left="267" width="2" height="9" font="3"> </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="18" size="6" family="Times New Roman" color="#000000"/>
	<fontspec id="19" size="8" family="Times New Roman,Bold" color="#000000"/>
	<fontspec id="20" size="9" family="Times New Roman,Italic" color="#000000"/>
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="537" width="18" height="8" font="13"><b>3/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="75" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="72" left="102" width="102" height="16" font="9"><b>I.  Introduction </b></text>
<text top="89" left="123" width="1" height="5" font="8"> </text>
<text top="95" left="123" width="1" height="5" font="8"> </text>
<text top="100" left="123" width="11" height="11" font="3">1. </text>
<text top="100" left="147" width="343" height="11" font="3">Corruption can have a devastating effect on good governance, the rule of law, </text>
<text top="112" left="123" width="367" height="11" font="3">development and the equitable enjoyment of  all human rights, including the right to </text>
<text top="124" left="123" width="367" height="11" font="3">health.  Corruption  has  been the  subject  of international legal  commitments  as  well </text>
<text top="136" left="123" width="367" height="11" font="3">as  recent  political  commitments.  The  2030  Agenda  for  Sustainable  Development </text>
<text top="148" left="123" width="368" height="11" font="3">and  the  Sustainable  Development  Goals  (targets  16.5  and  16.6)  stipulate  that </text>
<text top="160" left="123" width="367" height="11" font="3">corruption  and  bribery,  in  all  their  forms,  should  be  substantially  reduced  by  2030 </text>
<text top="172" left="123" width="367" height="11" font="3">and  that  effective,  accountable  and  transparent  institutions  should  be  developed  at </text>
<text top="184" left="123" width="44" height="11" font="3">all levels. </text>
<text top="202" left="123" width="11" height="11" font="3">2. </text>
<text top="202" left="147" width="344" height="11" font="3">While  corruption  manifests  at  many  levels  within  societies  and  States,  the </text>
<text top="214" left="123" width="367" height="11" font="3">present  report  focuses  on  the  links  between  corruption  and  the  enjoyment  of  the </text>
<text top="226" left="123" width="367" height="11" font="3">right  to  the  highest  attainable  standard  of  health.  Corruption  in  government, </text>
<text top="238" left="123" width="368" height="11" font="3">institutions and society at large is a significant obstacle to the enjoyme nt of the right </text>
<text top="250" left="123" width="367" height="11" font="3">to  health  of  individuals  and  groups.  In  countries  with  a  higher  level  of  perceived </text>
<text top="262" left="123" width="299" height="11" font="3">national corruption, there is a much higher prevalence of poor health.</text>
<text top="262" left="424" width="3" height="6" font="18">1</text>
<text top="262" left="427" width="64" height="11" font="3"> Corruption in </text>
<text top="274" left="123" width="368" height="11" font="3">Government and society can reduce the ability of the government to rais e resources </text>
<text top="286" left="123" width="367" height="11" font="3">for  health  and  other  social  sectors  through  putting  off  investors  or  donors  or  as  a </text>
<text top="298" left="123" width="96" height="11" font="3">result of tax evasion.  </text>
<text top="316" left="123" width="11" height="11" font="3">3. </text>
<text top="316" left="147" width="274" height="11" font="3">In  many  countries  health  is  among  the  most  corrupt  sectors.</text>
<text top="316" left="422" width="3" height="6" font="18">2</text>
<text top="316" left="425" width="66" height="11" font="3">  Health  sector </text>
<text top="328" left="123" width="368" height="11" font="3">corruption,  including  for  example  the  bribing  of  health  officials  and  unofficial </text>
<text top="340" left="123" width="367" height="11" font="3">payments to health-care providers, obstructs the ability of States to fulfil their right </text>
<text top="352" left="123" width="367" height="11" font="3">to  health  obligation  and  to  guarantee  available,  accessible,  acceptable  and  good </text>
<text top="364" left="123" width="197" height="11" font="3">quality  health  services,  goods  and  facilities.</text>
<text top="364" left="322" width="3" height="6" font="18">3</text>
<text top="364" left="325" width="166" height="11" font="3">  Yet  corruption  affecting  health  also </text>
<text top="376" left="123" width="367" height="11" font="3">occurs  in  other  sectors  and  industries,  for  example,  the  water  sector,  and  the  food </text>
<text top="388" left="123" width="367" height="11" font="3">and  beverages,  tobacco  and  other  industries.  Moreover,  corruption  has  significant </text>
<text top="400" left="123" width="368" height="11" font="3">implications  for  equality  and  non-discrimination  since  it  has  a  particularly  marked </text>
<text top="412" left="123" width="367" height="11" font="3">impact  on  the  health  of  populations  in  situations  of  vulnerability  and  social </text>
<text top="424" left="123" width="258" height="11" font="3">exclusion, in particular those living in poverty and children.</text>
<text top="424" left="382" width="3" height="6" font="18">4</text>
<text top="426" left="386" width="2" height="9" font="3"> </text>
<text top="442" left="123" width="11" height="11" font="3">4. </text>
<text top="442" left="147" width="343" height="11" font="3">The right to health provides a valuable normative framework and constitutes a </text>
<text top="454" left="123" width="367" height="11" font="3">legally  binding  imperative  to  analyse  and  address  corruption  affecting  health  and </text>
<text top="466" left="123" width="367" height="11" font="3">occurring  in and  beyond the  health  sector. The  framework reflects  notions of  good </text>
<text top="478" left="123" width="367" height="11" font="3">governance,  transparency,  accountability  and  participation,  which  are  key  when  it </text>
<text top="490" left="123" width="367" height="11" font="3">comes  to  combating  corruption.  It  places  legal  obligations  on  States  to  guarantee </text>
<text top="502" left="123" width="367" height="11" font="3">access to health-related goods and services for all, including individuals and groups </text>
<text top="514" left="123" width="367" height="11" font="3">in  situations  of  vulnerability,  and  this  requires  them  to  take  actions  to  curb </text>
<text top="526" left="123" width="122" height="11" font="3">corruption where it occurs.  </text>
<text top="544" left="123" width="11" height="11" font="3">5. </text>
<text top="544" left="147" width="343" height="11" font="3">The present report is the result of extensive consultations among a wide range </text>
<text top="556" left="123" width="367" height="11" font="3">of stakeholders, including representatives of relevant United Nations agencies, civil </text>
<text top="568" left="123" width="367" height="11" font="3">society  and  academic  experts.  In  May  2017,  the  Special  Rapporteur  convened  an </text>
<text top="587" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="601" left="95" width="2" height="8" font="0"> </text>
<text top="599" left="117" width="3" height="5" font="18">1</text>
<text top="601" left="120" width="357" height="8" font="0">  Margot I. Witvliet and others, “Sick regimes and sick people: a multilevel investigation of the </text>
<text top="609" left="123" width="250" height="9" font="0">population health consequences of perceived national corruption”, </text>
<text top="609" left="374" width="87" height="9" font="20"><i>Tropical Medicine and </i></text>
<text top="620" left="123" width="77" height="9" font="20"><i>International Health</i></text>
<text top="620" left="201" width="282" height="9" font="0">, vol. 18, No. 10, pp. 1240-1247; Angela Maria Pinzon-Rondon and others, </text>
<text top="630" left="123" width="266" height="9" font="0">“Association of rule of law and health outcomes: an ecological study”, </text>
<text top="630" left="390" width="39" height="9" font="20"><i>BMJ Open</i></text>
<text top="630" left="430" width="58" height="9" font="0"> (2015), vol. 5, </text>
<text top="641" left="123" width="30" height="9" font="0">No. 10. </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="117" width="3" height="5" font="18">2</text>
<text top="653" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="651" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="651" left="348" width="129" height="9" font="0">, part one, Corruption and health,  </text>
<text top="662" left="123" width="36" height="9" font="0">pp. 3-22. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="117" width="3" height="5" font="18">3</text>
<text top="674" left="120" width="259" height="8" font="0">  Brigit C.A. Toebes, “Human rights and health sector corruption”, in </text>
<text top="672" left="380" width="101" height="9" font="20"><i>Global Health and Human </i></text>
<text top="683" left="123" width="23" height="9" font="20"><i>Rights</i></text>
<text top="683" left="147" width="333" height="9" font="0">, John Harrington and Maria Stuttaford, eds. (London and New York, Routledge,  2010),  </text>
<text top="693" left="123" width="50" height="9" font="0">pp. 102-134. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="117" width="3" height="5" font="18">4</text>
<text top="706" left="120" width="359" height="8" font="0">  Witvliet and others, “Sick regimes and sick people”, pp. 1245-1246; see also Mogens Justesen </text>
<text top="714" left="123" width="355" height="9" font="0">and Christian Bjørnskov, “Exploiting the poor: bureaucratic corruption and poverty in Africa”, </text>
<text top="725" left="123" width="215" height="9" font="0">World Development, vol. 58, No. C (2014), pp. 106-115. </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="21" size="10" family="Times New Roman" color="#0000ff"/>
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="18" height="8" font="13"><b>4/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">expert  consultation  in  Bangkok  and  is  very  grateful  to  those  who  participated  and </text>
<text top="85" left="123" width="206" height="11" font="3">provided valuable inputs for the present report. </text>
<text top="104" left="123" width="1" height="5" font="8"> </text>
<text top="110" left="123" width="1" height="5" font="8"> </text>
<text top="117" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="114" left="97" width="375" height="16" font="9"><b>II.  Corruption and the right to health: key issues and trends </b></text>
<text top="131" left="123" width="1" height="5" font="8"> </text>
<text top="137" left="123" width="1" height="5" font="8"> </text>
<text top="142" left="123" width="11" height="11" font="3">6. </text>
<text top="142" left="147" width="344" height="11" font="3">Corruption is generally defined as “the misuse of public or entrusted po wer for </text>
<text top="154" left="123" width="63" height="11" font="3">private  gain”.</text>
<text top="154" left="187" width="3" height="6" font="18">5</text>
<text top="154" left="190" width="301" height="11" font="3">  In  relation  to  health,  in  many  countries  varying  degrees  of </text>
<text top="166" left="123" width="367" height="11" font="3">responsibility for public roles is entrusted to private actors, including private health </text>
<text top="178" left="123" width="367" height="11" font="3">professionals,  pharmaceutical  companies  and  health  insurance  companies. </text>
<text top="190" left="123" width="249" height="11" font="3">Corruption occurs in both the public and private sectors.  </text>
<text top="208" left="123" width="11" height="11" font="3">7. </text>
<text top="208" left="147" width="343" height="11" font="3">A  distinction  is  frequently  made  between  “grand”  and  “petty”  corruption. </text>
<text top="220" left="123" width="367" height="11" font="3">Grand  or  “high-level”  corruption  refers  to  acts  committed  at  a  high  level  of </text>
<text top="232" left="123" width="368" height="11" font="3">government  that  distort  policies  of  the  central  government,  for  example  a  heal th </text>
<text top="244" left="123" width="367" height="11" font="3">minister  “skimming”  money  off  a  loan  from  a  foreign  country.  Petty  or </text>
<text top="256" left="123" width="368" height="11" font="3">“administrative”  corruption  is  smaller-scale  everyday  corruption  by  low-  and </text>
<text top="268" left="123" width="367" height="11" font="3">mid-level public officials in their interaction with citizens, for example an informal </text>
<text top="280" left="123" width="136" height="11" font="3">payment from patient to doctor.</text>
<text top="280" left="260" width="3" height="6" font="18">6</text>
<text top="280" left="263" width="5" height="11" font="3">  </text>
<text top="298" left="123" width="11" height="11" font="3">8. </text>
<text top="298" left="147" width="343" height="11" font="3">Other definitions distinguish between types of corruption,  which among other </text>
<text top="310" left="123" width="367" height="11" font="3">forms  include  political  and  institutional  corruption.  “Political  corruption”  means </text>
<text top="322" left="123" width="368" height="11" font="3">manipulation  by  political  decision  makers  of,  for  example,  policies  and  rules  of </text>
<text top="334" left="123" width="367" height="11" font="3">procedure in the allocation of resources, such as a government accepting a bribe in </text>
<text top="346" left="123" width="367" height="11" font="3">exchange for the construction of a large private hospital in the capital. “Institutional </text>
<text top="358" left="123" width="367" height="11" font="3">corruption”  results  from  the  normalization  of  behaviours  that  compromise </text>
<text top="370" left="123" width="367" height="11" font="3">truth-seeking  and  lead  to  the  formation  of  perverse  incentive  structures,  and  thus </text>
<text top="382" left="123" width="367" height="11" font="3">addresses  the  behaviour  of  actors  who  exploit  their  institutional  positions  to </text>
<text top="394" left="123" width="192" height="11" font="3">influence institutional processes and actions.</text>
<text top="394" left="316" width="3" height="6" font="18">7</text>
<text top="394" left="320" width="5" height="11" font="3">  </text>
<text top="412" left="123" width="11" height="11" font="3">9. </text>
<text top="412" left="147" width="344" height="11" font="3">All in all, corruption is a multidisciplinary phenomenon demanding a response </text>
<text top="424" left="123" width="367" height="11" font="3">from many fields of study. From a legal perspective, the United Nations Convention </text>
<text top="436" left="123" width="224" height="11" font="3">against  Corruption  (General  Assembly  resolution </text>
<text top="436" left="351" width="19" height="11" font="21"><a href="https://undocs.org/A/RES/58/4">58/4</a></text>
<text top="436" left="370" width="121" height="11" font="3"><a href="https://undocs.org/A/RES/58/4">,</a>  annex)  lists  five  acts  of </text>
<text top="448" left="123" width="295" height="11" font="3">corruption, which can be translated as follows to the health context: </text>
<text top="468" left="123" width="2" height="9" font="3"> </text>
<text top="466" left="147" width="343" height="11" font="3">(a)  The  bribery  of  national  and  foreign  public  officials  in  exchange  for  an </text>
<text top="478" left="123" width="78" height="11" font="3">undue advantage; </text>
<text top="498" left="123" width="2" height="9" font="3"> </text>
<text top="496" left="147" width="343" height="11" font="3">(b)  Embezzlement,  misappropriation  or  other  diversion  of  funds  from  the </text>
<text top="508" left="123" width="149" height="11" font="3">health budget by a public official; </text>
<text top="528" left="123" width="2" height="9" font="3"> </text>
<text top="526" left="147" width="117" height="11" font="3">(c)  Trading in influence; </text>
<text top="546" left="123" width="2" height="9" font="3"> </text>
<text top="544" left="147" width="114" height="11" font="3">(d)  Abuse of functions;  </text>
<text top="564" left="123" width="2" height="9" font="3"> </text>
<text top="562" left="147" width="101" height="11" font="3">(e)  Illicit enrichment.</text>
<text top="562" left="248" width="3" height="6" font="18">8</text>
<text top="562" left="252" width="5" height="11" font="3">  </text>
<text top="580" left="123" width="367" height="11" font="3">10.  There  are  many  other  manifestations  of  corruption  in  the  health  sector  and </text>
<text top="592" left="123" width="367" height="11" font="3">beyond. The present report focuses on several non-exhaustive, illustrative examples. </text>
<text top="610" left="123" width="367" height="11" font="3">11.  Both  corruption  occurring  in  society  at  large  (general  corruption),  as  well  as </text>
<text top="622" left="123" width="368" height="11" font="3">corruption specifically occurring in the health or other health -related sectors, have a </text>
<text top="634" left="123" width="367" height="11" font="3">negative  impact  on  the  enjoyment  of  the  right  to  health.  These  forms  are </text>
<text top="650" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="664" left="95" width="2" height="8" font="0"> </text>
<text top="662" left="117" width="3" height="5" font="18">5</text>
<text top="664" left="120" width="335" height="8" font="0">  Transparency International, “Frequently asked questions on corrupt ion”. Available from </text>
<text top="672" left="123" width="322" height="9" font="0">www.transparency.org/whoweare/organisation/faqs_on_corruption#defineCorruption.  </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="117" width="3" height="5" font="18">6</text>
<text top="685" left="120" width="296" height="8" font="0">  Transparency International, “How do you define corruption?”. Available from </text>
<text top="693" left="123" width="212" height="9" font="12"><a href="https://www.transparency.org/what-is-corruption/#define">https://www.transparency.org/what-is-corruption/#define</a></text>
<text top="693" left="336" width="5" height="9" font="0"><a href="https://www.transparency.org/what-is-corruption/#define">.</a> </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="117" width="3" height="5" font="18">7</text>
<text top="706" left="120" width="239" height="8" font="0">  Lawrence Lessig, “‘Institutional corruption’ defined” foreword</text>
<text top="704" left="359" width="119" height="9" font="20"><i>, Journal of Law, Medicine and </i></text>
<text top="714" left="123" width="23" height="9" font="20"><i>Ethics</i></text>
<text top="714" left="147" width="146" height="9" font="0">, vol. 41, No. 3 (2013). Available from<a href="https://ssrn.com/abstract=2295067"> </a></text>
<text top="714" left="293" width="129" height="9" font="12"><a href="https://ssrn.com/abstract=2295067">https://ssrn.com/abstract=2295067</a></text>
<text top="714" left="422" width="7" height="9" font="0"><a href="https://ssrn.com/abstract=2295067">. </a> </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="117" width="3" height="5" font="18">8</text>
<text top="727" left="120" width="206" height="8" font="0">  Toebes, “Human rights and health sector corruption”.  </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="537" width="18" height="8" font="13"><b>5/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">intertwined.  Corruption  in  society  at  large  may  affect  the  regulatory  environment </text>
<text top="85" left="123" width="368" height="11" font="3">and the efficiency of State institutions. It hinders economic growth   and  sustainable </text>
<text top="97" left="123" width="264" height="11" font="3">development  as  well  as  equitable  distribution  of  resources.</text>
<text top="97" left="388" width="3" height="6" font="18">9</text>
<text top="97" left="392" width="99" height="11" font="3">  It  undermines  public </text>
<text top="109" left="123" width="367" height="11" font="3">confidence  in  the  State  and  may  obstruct  attainment  of  the  commitments  made </text>
<text top="121" left="123" width="367" height="11" font="3">through  Sustainable  Development  Goal  16  to  create  effective  and  accountable </text>
<text top="133" left="123" width="56" height="11" font="3">institutions.  </text>
<text top="151" left="123" width="367" height="11" font="3">12.  Corruption is particularly detrimental in that it increases mistrust on the part of </text>
<text top="163" left="123" width="368" height="11" font="3">all stakeholders, especially  users of services, not only in the health-care system but </text>
<text top="175" left="123" width="367" height="11" font="3">also  in  the  abilities  and  performance  of  local  and  national  authorities  in  general. </text>
<text top="187" left="123" width="367" height="11" font="3">While little research has been done on the impact of corruption on health outcomes, </text>
<text top="199" left="123" width="367" height="11" font="3">it  is  suggested,  for  example,  that  countries  with  higher  levels  of  corruption  have </text>
<text top="211" left="123" width="135" height="11" font="3">higher levels of child mortality.</text>
<text top="211" left="259" width="6" height="6" font="18">10</text>
<text top="211" left="266" width="5" height="11" font="3">  </text>
<text top="229" left="123" width="367" height="11" font="3">13.  Alongside  general  corruption,  health  sector  corruption  is  widespread  and  has </text>
<text top="241" left="123" width="367" height="11" font="3">serious  consequences  for  the  enjoyment  of  the  right  to  health  on  the  basis  of </text>
<text top="253" left="123" width="367" height="11" font="3">equality  and  non-discrimination.  The  most  common  forms  of  corruption  in  the </text>
<text top="265" left="123" width="367" height="11" font="3">health  sector  are  selling  government  posts,  absenteeism,  bribes,  procurement </text>
<text top="277" left="123" width="367" height="11" font="3">corruption,  theft  or  misuse  of  property,  fraud,  and  embezzlement  of  user  fee </text>
<text top="289" left="123" width="300" height="11" font="3">revenue,  as  well  as  informal  payments  to  health-care  providers.</text>
<text top="289" left="424" width="6" height="6" font="18">11</text>
<text top="289" left="431" width="60" height="11" font="3">  A  range  of </text>
<text top="301" left="123" width="367" height="11" font="3">stakeholders  may  be  implicated  in  these  and  other  corrupt  practices  in  the  health </text>
<text top="313" left="123" width="367" height="11" font="3">sector  affecting  the  enjoyment  of  the  right  to  health.  These  include  but  are  not </text>
<text top="325" left="123" width="367" height="11" font="3">limited to health ministers, parliaments, accrediting and licensing bodies, public and </text>
<text top="337" left="123" width="367" height="11" font="3">private insurers, hospitals, health professionals and health professional associations, </text>
<text top="349" left="123" width="367" height="11" font="3">community  health  workers,  pharmacists,  pharmaceutical  companies  and </text>
<text top="361" left="123" width="368" height="11" font="3">biotechnology  companies,  medical  researchers  and  medical  researc h  groups  and </text>
<text top="373" left="123" width="166" height="11" font="3">patients  and  patient  support  groups.</text>
<text top="373" left="290" width="6" height="6" font="18">12</text>
<text top="373" left="297" width="194" height="11" font="3">  As  will  be  argued  below,  they  all  bear </text>
<text top="385" left="123" width="214" height="11" font="3">responsibilities with regard to the right to health. </text>
<text top="403" left="123" width="367" height="11" font="3">14.  Corruption  is  a  significant  challenge  to  the  delivery  of  quality  health  care, </text>
<text top="415" left="123" width="367" height="11" font="3">which is central both to the right to health and to the commitment under Sustainable </text>
<text top="427" left="123" width="367" height="11" font="3">Development  Goal  3  to  universal  health  coverage.  The  health  sector  is  extremely </text>
<text top="439" left="123" width="368" height="11" font="3">vulnerable to corruption at all levels  — grand and petty, political and institutional  — </text>
<text top="451" left="123" width="367" height="11" font="3">and  occurring  in  both  the  public  and  private  sectors.  It  is  estimated  that  every  year </text>
<text top="463" left="123" width="325" height="11" font="3">180  billion  euros  are  lost  to  fraud  and  corruption  in  health  care  globally.</text>
<text top="463" left="450" width="6" height="6" font="18">13</text>
<text top="463" left="456" width="35" height="11" font="3">  Health </text>
<text top="475" left="123" width="367" height="11" font="3">sector corruption negatively affects the (financial) resources available for health care; </text>
<text top="487" left="123" width="367" height="11" font="3">resources that are drained through embezzlement and procurement fraud are no longer </text>
<text top="499" left="123" width="338" height="11" font="3">available  for  paying  salaries,  funding  health-care  delivery  or  maintenance.</text>
<text top="499" left="462" width="6" height="6" font="18">14</text>
<text top="499" left="468" width="23" height="11" font="3">  For </text>
<text top="511" left="123" width="367" height="11" font="3">example,  there  is  evidence  suggesting  that  health  sector  corruption  has  a  negative </text>
<text top="566" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="579" left="95" width="2" height="8" font="0"> </text>
<text top="578" left="117" width="3" height="5" font="18">9</text>
<text top="579" left="120" width="365" height="8" font="0">  Marie Chêne, “The impact of corruption on growth and inequality” (Transparency International, </text>
<text top="588" left="123" width="348" height="9" font="0">March 2014); and Kwabena Gyimah-Brempong, “Corruption, economic growth, and income </text>
<text top="599" left="123" width="355" height="9" font="0">inequality in Africa”, Economics of Governance, Springer-Verlag, No. 3: (2002), pp. 183-209. </text>
<text top="611" left="95" width="2" height="8" font="0"> </text>
<text top="609" left="114" width="6" height="5" font="18">10</text>
<text top="611" left="120" width="365" height="8" font="0">  Sanjeev Gupta and others, “Corruption and the provision of health care and education services”, </text>
<text top="620" left="123" width="361" height="9" font="0">International Monetary Fund working paper, June 2000, p. 8; see also Witvliet and others, “Sick </text>
<text top="630" left="123" width="132" height="9" font="0">regimes and sick people”, p. 1245. </text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">11</text>
<text top="643" left="120" width="348" height="8" font="0">  Taryn Vian, “Review of corruption in the health sector: theory, methods and interventions”, </text>
<text top="651" left="123" width="104" height="9" font="20"><i>Health Policy and Planning</i></text>
<text top="651" left="228" width="255" height="9" font="0"> (2008), vol. 23, No. 2, pp. 83-94; and U4 Anti-Corruption Training </text>
<text top="662" left="123" width="349" height="9" font="0">Course. Available from www.bu.edu/actforhealth/CorruptionInHealthforce/Reader%201.pdf.  </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">12</text>
<text top="674" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="672" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="672" left="348" width="41" height="9" font="0">, pp. 4-13. </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">13</text>
<text top="685" left="120" width="341" height="8" font="0">  University of Portsmouth, Centre for Counter Fraud Studies and MacIntyre Hudson, “The </text>
<text top="693" left="123" width="322" height="9" font="0">financial cost of healthcare fraud”, available from www.macintyrehudson.co.uk/sites/  </text>
<text top="704" left="123" width="361" height="9" font="0">www.macintyrehudson.co.uk/files/The%20Financial%20Cost%20of%20Healthcare%20Fraud%2</text>
<text top="714" left="123" width="69" height="9" font="0">0-%20Report.pdf. </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">14</text>
<text top="727" left="120" width="145" height="8" font="0">  U4 Anti-Corruption Training Course. </text>
</page>
<page number="6" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="18" height="8" font="13"><b>6/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="207" height="11" font="3">effect  on  cancer  care  and  care  for  HIV/AIDS.</text>
<text top="73" left="331" width="6" height="6" font="18">15</text>
<text top="73" left="337" width="154" height="11" font="3">  While  these  trends  are  visible  in </text>
<text top="85" left="123" width="368" height="11" font="3">countries  at  all  levels  of  development,  it  is  evident  that  lower-income  countries  are </text>
<text top="97" left="123" width="367" height="11" font="3">more deeply affected by health sector corruption and a lack of transparency. In some </text>
<text top="109" left="123" width="329" height="11" font="3">countries, the health sector is considered to be the most corrupt sector of all.  </text>
<text top="127" left="123" width="367" height="11" font="3">15.  The  lesser  form  of  corruption,  namely,  petty  corruption,  is  quite  common  in </text>
<text top="139" left="123" width="368" height="11" font="3">the  health  sector  and  includes  informal  payments  from  patient  to  health -care </text>
<text top="151" left="123" width="368" height="11" font="3">provider, absenteeism of health personnel and preferential treatment. These forms of </text>
<text top="163" left="123" width="367" height="11" font="3">corruption are also sometimes called “survival corruption”, as they are exacerbated </text>
<text top="175" left="123" width="367" height="11" font="3">by a lack of resources in health-care settings, poor working conditions, low pay, and </text>
<text top="187" left="123" width="368" height="11" font="3">hierarchical structures, which drive people to engage in such acts. There is evidence </text>
<text top="199" left="123" width="367" height="11" font="3">that this “microform” of corruption has a particularly negative effect on the poor in </text>
<text top="211" left="123" width="347" height="11" font="3">society, as they are often unable to pay the bribes necessary for a certain service.</text>
<text top="211" left="472" width="6" height="6" font="18">16</text>
<text top="211" left="478" width="5" height="11" font="3">  </text>
<text top="229" left="123" width="368" height="11" font="3">16.  Three  main  characteristics  make  the  health  sector  particularly  vulnerable  to </text>
<text top="241" left="123" width="368" height="11" font="3">corruption:  (a)  power  asymmetries  or  an  imbalance  of  information,  inter  alia , </text>
<text top="253" left="123" width="367" height="11" font="3">between  health-care  provider  and  patient  and  between  government,  the  private </text>
<text top="265" left="123" width="367" height="11" font="3">sector  and  rights  holders;  (b)  uncertainty  inherent  in  selecting,  monitoring, </text>
<text top="277" left="123" width="367" height="11" font="3">measuring  and  delivering  health-care  services;  and  (c)  the  complexity  of  health </text>
<text top="289" left="123" width="367" height="11" font="3">systems:  the  large  number  of  parties  involved  makes  it  more  difficult  to  generate </text>
<text top="301" left="123" width="222" height="11" font="3">and  analyse  information  in  a  transparent  manner.</text>
<text top="301" left="346" width="6" height="6" font="18">17</text>
<text top="301" left="352" width="139" height="11" font="3">  A  fourth  problem,  sometimes </text>
<text top="313" left="123" width="367" height="11" font="3">termed  “provider  moral  hazard”,  is  that  health  professionals,  public  officials  or </text>
<text top="325" left="123" width="367" height="11" font="3">private actors may choose to act in their own interests rather than in the interests of </text>
<text top="337" left="123" width="367" height="11" font="3">the rights holders towards whom they bear duties. Moreover,  where health systems </text>
<text top="349" left="123" width="367" height="11" font="3">lack  transparency,  participation  and  accountability,  a  fertile  breeding  ground  is </text>
<text top="361" left="123" width="102" height="11" font="3">created for corruption.  </text>
<text top="379" left="123" width="367" height="11" font="3">17.  Health  reforms  introduce  organizational  changes  that  can  mitigate  corruption </text>
<text top="391" left="123" width="367" height="11" font="3">but  may  also  open  new  channels  for  abuse.  As  discussed  during  the  expert </text>
<text top="403" left="123" width="367" height="11" font="3">consultation held in Bangkok, transferring responsibility for public health facilities </text>
<text top="415" left="123" width="367" height="11" font="3">from  national  to  local  governments  may  make  them  more  accountable  and  less </text>
<text top="427" left="123" width="367" height="11" font="3">corrupt, but it can also create opportunities for local officials to divert resources for </text>
<text top="439" left="123" width="367" height="11" font="3">personal gain. Deregulation can eliminate requirements that are exploited by public </text>
<text top="451" left="123" width="367" height="11" font="3">officials  to  charge  bribes,  but  it  can  also  eliminate  rules  and  oversight  that  are </text>
<text top="463" left="123" width="367" height="11" font="3">necessary  to  protect  the  public  against  unscrupulous  actors.  Permitting  doctors  to </text>
<text top="475" left="123" width="367" height="11" font="3">combine public and private practices is often justified as assuring staffing of public </text>
<text top="487" left="123" width="367" height="11" font="3">facilities, but may create situations where patients cannot obtain treatment to which </text>
<text top="499" left="123" width="367" height="11" font="3">they  are  entitled  in  public  facilities,  either  because  doctors  are  unavailable  or </text>
<text top="511" left="123" width="239" height="11" font="3">because they encourage patients to see them privately.  </text>
<text top="529" left="123" width="367" height="11" font="3">18.  The  Special  Rapporteur  is  concerned  that  there  is  a  “normalization  of </text>
<text top="541" left="123" width="367" height="11" font="3">corruption” in health care; corruption can be so pervasive that it becomes accepted </text>
<text top="553" left="123" width="60" height="11" font="3">as  “normal”.</text>
<text top="553" left="184" width="6" height="6" font="18">18</text>
<text top="553" left="190" width="301" height="11" font="3">  Yet  these  practices  lead  to  groups  and  individuals  being </text>
<text top="565" left="123" width="367" height="11" font="3">disadvantaged and to the infringement of human rights, such as access to health care </text>
<text top="577" left="123" width="367" height="11" font="3">on the basis of equality and non-discrimination. Changing views and perceptions in </text>
<text top="589" left="123" width="367" height="11" font="3">institutions  and  society  of  corruption  as  normal,  unavoidable  and  justified  is  an </text>
<text top="601" left="123" width="367" height="11" font="3">important element in  addressing the problem  of  corruption. Informal payments  can </text>
<text top="613" left="123" width="367" height="11" font="3">be reduced by engaging with the public in a debate about the adverse consequences </text>
<text top="625" left="123" width="367" height="11" font="3">of  corruption,  with  a  view  to  changing  cultural  values  in  relation  to  corruption. </text>
<text top="650" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="664" left="95" width="2" height="8" font="0"> </text>
<text top="662" left="114" width="6" height="5" font="18">15</text>
<text top="664" left="120" width="355" height="8" font="0">  Saskia Mostert and others, “Corruption in health-care systems and its effect on cancer care in </text>
<text top="672" left="123" width="32" height="9" font="0">Africa”, </text>
<text top="672" left="156" width="63" height="9" font="20"><i>Lancet Oncology</i></text>
<text top="672" left="220" width="246" height="9" font="0">; vol. 16, No. 8 (August 2015), pp. 394-404, and Willa Friedman, </text>
<text top="683" left="123" width="366" height="9" font="0">“Corruption and averting AIDS deaths”, Center for Global Development, working paper No. 395, </text>
<text top="693" left="123" width="59" height="9" font="0">February 2015. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">16</text>
<text top="706" left="120" width="357" height="8" font="0">  Justesen and Bjørnskov, “Exploiting the poor: bureaucratic corruption and poverty in Africa”.  </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">17</text>
<text top="716" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="714" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="714" left="348" width="34" height="9" font="0">, p. xvii. </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">18</text>
<text top="727" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="725" left="229" width="137" height="9" font="20"><i>Diagnosing corruption in healthcare</i></text>
<text top="725" left="366" width="71" height="9" font="0"> (2016), foreword. </text>
</page>
<page number="7" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="537" width="18" height="8" font="13"><b>7/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">Codes  of  conduct  and  ethics,  training  and  education  can  also  be  used  to  support </text>
<text top="85" left="123" width="367" height="11" font="3">responsible  conduct  among  professionals,  including  avoiding  corrupt  behaviour, </text>
<text top="97" left="123" width="367" height="11" font="3">although  they  may  not  be  sufficient  alone  for  behaviour  change  where  it  is  most </text>
<text top="109" left="123" width="367" height="11" font="3">needed. States should also take action to address other trigger factors such as low or </text>
<text top="121" left="123" width="345" height="11" font="3">unpaid salaries, cumbersome administrative procedures and excessive red tape,</text>
<text top="121" left="470" width="6" height="6" font="18">19</text>
<text top="121" left="476" width="15" height="11" font="3"> as </text>
<text top="133" left="123" width="281" height="11" font="3">well as enhancing transparency, participation and accountability.  </text>
<text top="151" left="123" width="368" height="11" font="3">19.  Beyond  the  health  sector,  corrupt  practices  that  have  a  direct  impact  on  the </text>
<text top="163" left="123" width="367" height="11" font="3">right  to  health  have  occurred  in  other  private  sector  companies,  including  private </text>
<text top="175" left="123" width="367" height="11" font="3">water  companies,  tobacco  manufacturers,  food  and  beverage  manufacturers,  car </text>
<text top="187" left="123" width="284" height="11" font="3">manufacturers  and  the  natural  resources  extraction  industry.</text>
<text top="187" left="408" width="6" height="6" font="18">20</text>
<text top="187" left="414" width="77" height="11" font="3">  Such  practices </text>
<text top="199" left="123" width="367" height="11" font="3">include,  for  example,  bribery  of  public  officials  and  the  manipulation  of  scientific </text>
<text top="211" left="123" width="80" height="11" font="3">research practices.</text>
<text top="211" left="204" width="6" height="6" font="18">21</text>
<text top="211" left="210" width="280" height="11" font="3"> In his previous reports, the Special Rapporteur has highlighted </text>
<text top="223" left="123" width="367" height="11" font="3">how  power  asymmetries  have  given  rise  to  the  widespread  prioritizing  of </text>
<text top="235" left="123" width="367" height="11" font="3">specialized  medicine  over  primary  care  and  public  health  interventions,  including </text>
<text top="247" left="123" width="367" height="11" font="3">poverty  reduction,  labour  conditions  and  early  childhood  services  (see </text>
<text top="259" left="123" width="59" height="11" font="21"><a href="https://undocs.org/A/HRC/35/21">A/HRC/35/21</a></text>
<text top="259" left="183" width="307" height="11" font="3"><a href="https://undocs.org/A/HRC/35/21">,</a>  paras.  21-26).  Such  asymmetries  generate  preferences  for  physical </text>
<text top="271" left="123" width="368" height="11" font="3">health  care  over  mental  health  care;  biomedical  interventions  over  non -biomedical </text>
<text top="283" left="123" width="367" height="11" font="3">interventions;  the  prioritization  of  certain  disciplines  that  promote  expensive </text>
<text top="295" left="123" width="367" height="11" font="3">biomedical technologies over social sciences in public health research agendas; and </text>
<text top="307" left="123" width="296" height="11" font="3">limited space for civil society participation in health policymaking.   </text>
<text top="325" left="123" width="368" height="11" font="3">20.  Although  many  everyday  practices  in  health-related  services  may  not  be </text>
<text top="337" left="123" width="367" height="11" font="3">considered as corruption, legally speaking, their accumulation and their acceptance </text>
<text top="349" left="123" width="367" height="11" font="3">by various stakeholders have a detrimental cumulative effect on the performance of </text>
<text top="361" left="123" width="367" height="11" font="3">health-care  systems  and,  indirectly,  on  individual  and  societal  health.  It  is  for  that </text>
<text top="373" left="123" width="367" height="11" font="3">reason that the present report is focused not only on those forms of corruption that </text>
<text top="385" left="123" width="367" height="11" font="3">are legally defined as breaking the law and should be brought to justice, but also on </text>
<text top="397" left="123" width="367" height="11" font="3">those practices which undermine principles of medical ethics, social justice, as well </text>
<text top="409" left="123" width="367" height="11" font="3">as  effective  and  transparent  health-care  provision.  When  such  practices  are  not </text>
<text top="421" left="123" width="367" height="11" font="3">properly  addressed,  they  pave  the  way  to  non-transparent  decisions  at  all  levels  of </text>
<text top="433" left="123" width="368" height="11" font="3">policymaking,  policy  implementation  and  services  provision  and  thus  lead  to </text>
<text top="445" left="123" width="248" height="11" font="3">corrupt environments and foster institutional corruption.  </text>
<text top="463" left="123" width="367" height="11" font="3">21.  Mindful  that  the  nature  of  corruption  means  that  it  is  often  difficult  to </text>
<text top="475" left="123" width="368" height="11" font="3">distinguish  intentional  malfeasance  from  inefficiencies,  errors,  and  differences  in </text>
<text top="487" left="123" width="127" height="11" font="3">judgments  and  in  priorities,</text>
<text top="487" left="250" width="6" height="6" font="18">22</text>
<text top="487" left="257" width="234" height="11" font="3">  the  Special  Rapporteur  underlines  that  enhancing </text>
<text top="499" left="123" width="367" height="11" font="3">transparency is particularly important not only to address clearly corrupt practices but </text>
<text top="511" left="123" width="367" height="11" font="3">also to address these  harmful phenomena,  which obstruct the enjoyment of the right </text>
<text top="523" left="123" width="45" height="11" font="3">to health.  </text>
<text top="541" left="123" width="367" height="11" font="3">22.  In  the  context  of  universal  health  coverage,  as  one  of  the  important  global </text>
<text top="553" left="123" width="368" height="11" font="3">commitments under the 2030 Agenda, it is critical to strengthen health -care systems </text>
<text top="565" left="123" width="367" height="11" font="3">so that all segments of population trust primary care and primarily use this level of </text>
<text top="577" left="123" width="368" height="11" font="3">services  for  most  health  conditions.  This  would  be  an  effective  anti-corruption </text>
<text top="597" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="611" left="95" width="2" height="8" font="0"> </text>
<text top="609" left="114" width="6" height="5" font="18">19</text>
<text top="611" left="120" width="335" height="8" font="0">  Jon S.T. Quah, “The normalization of corruption: why it occurs and what can be done to </text>
<text top="620" left="123" width="352" height="9" font="0">minimize it”, Department of Economic and Social Affairs, Division for Public Administration </text>
<text top="630" left="123" width="227" height="9" font="0">and Development Management, Singapore, December 2015. </text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">20</text>
<text top="643" left="120" width="19" height="8" font="0">  See<a href="https://www.transparency.org/topic/detail/water"> </a></text>
<text top="641" left="139" width="177" height="9" font="12"><a href="https://www.transparency.org/topic/detail/water">https://www.transparency.org/topic/detail/water</a></text>
<text top="641" left="317" width="170" height="9" font="0"><a href="https://www.transparency.org/topic/detail/water">; </a>Transparency International, Policy Position </text>
<text top="651" left="123" width="338" height="9" font="0">No. 2, 2008, “Linking the corruption, water and environmental agendas to combat climate </text>
<text top="662" left="123" width="106" height="9" font="0">change”, 15 February 2008. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">21</text>
<text top="674" left="120" width="358" height="8" font="0">  Pascal A. Diethelm, Jean-Charles Rielle and Martin McKee, “The whole truth and nothing but </text>
<text top="683" left="123" width="253" height="9" font="0">the truth? The research that Philip Morris did not want you to see”, </text>
<text top="683" left="377" width="25" height="9" font="20"><i>Lancet</i></text>
<text top="683" left="402" width="77" height="9" font="0">, vol. 366, No. 9479 </text>
<text top="693" left="123" width="95" height="9" font="0">(2 July 2005), pp. 86-92. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">22</text>
<text top="706" left="120" width="369" height="8" font="0">  William Savedoff, Amanda Glassman and Janeen Madan,  Center for Global Development, policy </text>
<text top="714" left="123" width="359" height="9" font="0">paper No. 86, “Global Health, Aid and Corruption: Can We Escape the Scandal Cycle?”, 2016,  </text>
<text top="725" left="123" width="19" height="9" font="0">p. 9. </text>
</page>
<page number="8" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="18" height="8" font="13"><b>8/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">measure  to  help  decrease  the  prevailing  tendency  whereby  users  of  health  services </text>
<text top="85" left="123" width="368" height="11" font="3">prefer to bypass primary care and use specialized health-care services. The Special </text>
<text top="97" left="123" width="367" height="11" font="3">Rapporteur  welcomes recent initiatives  developed  and  replicated in  some  countries </text>
<text top="109" left="123" width="367" height="11" font="3">through  which  medical  doctors  educate  the  general  population  against  wasteful  or </text>
<text top="121" left="123" width="367" height="11" font="3">unnecessary  use  of  medical  tests,  treatments  and  procedures  in  health  care.  Such </text>
<text top="133" left="123" width="365" height="11" font="3">initiatives, inter  alia,  “choosing  wisely”,  “realistic  medicines” or  “preventing over-</text>
<text top="145" left="123" width="367" height="11" font="3">diagnosis”, should be supported by States as effective measures to develop rational </text>
<text top="157" left="123" width="368" height="11" font="3">health-care  services  and  thus  prevent  unnecessary  and  costly  use  of  specialized </text>
<text top="169" left="123" width="62" height="11" font="3">interventions. </text>
<text top="188" left="123" width="1" height="5" font="8"> </text>
<text top="194" left="123" width="1" height="5" font="8"> </text>
<text top="201" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="198" left="91" width="366" height="16" font="9"><b>III.  Corruption and the normative framework of the right  </b></text>
<text top="213" left="123" width="57" height="16" font="9"><b>to health </b></text>
<text top="230" left="123" width="1" height="5" font="8"> </text>
<text top="236" left="123" width="1" height="5" font="8"> </text>
<text top="243" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="241" left="99" width="297" height="13" font="10"><b>A.  The right to health as a legally binding obligation </b></text>
<text top="255" left="123" width="1" height="5" font="8"> </text>
<text top="261" left="123" width="1" height="5" font="8"> </text>
<text top="267" left="123" width="367" height="11" font="3">23.  The  right  to  health  is  recognized  in  the  Constitution  of  the  World  Health </text>
<text top="279" left="123" width="368" height="11" font="3">Organization  (WHO)  and  protected  by  the  Universal  Declaration  of  Human  Rights </text>
<text top="291" left="123" width="367" height="11" font="3">and international human rights treaties which are binding on States parties, including </text>
<text top="303" left="123" width="367" height="11" font="3">the International Covenant on Economic, Social and Cultural Rights, the International </text>
<text top="315" left="123" width="368" height="11" font="3">Convention on the Elimination of All Forms of Racial Discrimination, the Convention </text>
<text top="327" left="123" width="367" height="11" font="3">on the Elimination of All Forms of Discrimination against Women, the Convention on </text>
<text top="339" left="123" width="367" height="11" font="3">the Rights of the Child, the Convention on the Rights of Persons with Disabilities and </text>
<text top="351" left="123" width="368" height="11" font="3">the International Convention on the Protection of the Rights of All Migrant Wo rkers </text>
<text top="363" left="123" width="367" height="11" font="3">and  Members  of  Their  Families.  Additionally,  regional  human  rights  treaties  and </text>
<text top="375" left="123" width="367" height="11" font="3">many  domestic  constitutions  protect  the  right  to  health.  These  international  treaties </text>
<text top="387" left="123" width="368" height="11" font="3">and domestic laws obligate States to take action to respect, protect and fulfil the  right </text>
<text top="399" left="123" width="368" height="11" font="3">to  health  and  to  address  corruption  where  it  interferes  with  their  right -to-health </text>
<text top="411" left="123" width="367" height="11" font="3">obligations.  They  should  inform  responses  to  corruption  alongside  other  legal </text>
<text top="423" left="123" width="307" height="11" font="3">instruments, such as the United Nations Convention against Corruption.  </text>
<text top="441" left="123" width="367" height="11" font="3">24.  The right to health gives rise to obligations that provide a framework for action </text>
<text top="453" left="123" width="367" height="11" font="3">for  duty  bearers,  as  well  as  a  framework  of  reference  for  monitoring  and </text>
<text top="465" left="123" width="305" height="11" font="3">accountability. The right to health is subject to progressive realization.</text>
<text top="465" left="430" width="6" height="6" font="18">23</text>
<text top="465" left="436" width="55" height="11" font="3"> This  means </text>
<text top="477" left="123" width="367" height="11" font="3">that many aspects of the right to health do not have to be realized immediately; rather, </text>
<text top="489" left="123" width="367" height="11" font="3">States  must  take  effective  and  targeted  measures  towards  the  progressive  realization </text>
<text top="501" left="123" width="367" height="11" font="3">of  the  right  to  health.  However,  States  also  have  some  immediate  obligations, </text>
<text top="513" left="123" width="367" height="11" font="3">including core obligations such as the equitable distribution of health facilities, goods </text>
<text top="525" left="123" width="367" height="11" font="3">and services; the provision of essential medicines; access to minimum essential food, </text>
<text top="537" left="123" width="367" height="11" font="3">basic  shelter,  safe  and  potable  water  and  sanitation;  and  the  adoption  of  a  national </text>
<text top="549" left="123" width="338" height="11" font="3">health strategy and plan of action on the basis of epidemiological information.</text>
<text top="549" left="463" width="6" height="6" font="18">24</text>
<text top="549" left="469" width="22" height="11" font="3"> The </text>
<text top="561" left="123" width="367" height="11" font="3">Committee  on  the  Rights  of  the  Child  has  also  highlighted  that  universal  health </text>
<text top="573" left="123" width="367" height="11" font="3">coverage is a core obligation (see the Committee’s general comment No. 15 (2013) on </text>
<text top="585" left="123" width="368" height="11" font="3">the  right  of  the  child  to  the  enjoyment  of  the  highest  attainable  standard  of  health, </text>
<text top="597" left="123" width="367" height="11" font="3">para.  72).  States  must  adopt  and  enforce  legislative,  regulatory  and  policy  measures </text>
<text top="609" left="123" width="367" height="11" font="3">to ensure that corruption does not impede the fulfilment of their progressive and core </text>
<text top="621" left="123" width="55" height="11" font="3">obligations.  </text>
<text top="681" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="695" left="95" width="2" height="8" font="0"> </text>
<text top="693" left="114" width="6" height="5" font="18">23</text>
<text top="695" left="120" width="352" height="8" font="0">  International Covenant on Economic, Social and Cultural Rights, art. 2.1; Convention on the </text>
<text top="704" left="123" width="101" height="9" font="0">Rights of the Child, art. 4. </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">24</text>
<text top="716" left="120" width="352" height="8" font="0">  Committee on Economic, Social and Cultural Rights, general comment No. 14 ( 2000) on the </text>
<text top="725" left="123" width="219" height="9" font="0">right to the highest attainable standard of health, para. 43. </text>
</page>
<page number="9" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="537" width="18" height="8" font="13"><b>9/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">25.  Corruption  undermines  the  State’s obligation  to  realize the right to  health  “to </text>
<text top="85" left="123" width="179" height="11" font="3">the maximum of its available resources”.</text>
<text top="85" left="303" width="6" height="6" font="18">25</text>
<text top="85" left="309" width="181" height="11" font="3"> Notably, embezzlement diverts financial </text>
<text top="97" left="123" width="367" height="11" font="3">resources  from  their  intended  purpose.  Corruption  also  reduces  the  ability  of </text>
<text top="109" left="123" width="367" height="11" font="3">governments  to  generate  maximum  resources,  including  through  international </text>
<text top="121" left="123" width="367" height="11" font="3">cooperation,  in  the  first  place  by  making  countries  less  attractive  to  donors  and </text>
<text top="133" left="123" width="49" height="11" font="3">investment,</text>
<text top="133" left="173" width="6" height="6" font="18">26</text>
<text top="133" left="180" width="311" height="11" font="3"> and may support tax evasion. Measures to prevent and protect against </text>
<text top="145" left="123" width="327" height="11" font="3">corruption offences are therefore an essential component of this obligation. </text>
<text top="163" left="123" width="367" height="11" font="3">26.  Moreover,  since  the  right  to  health  includes  not  only  a  right  to  health  care  but </text>
<text top="175" left="123" width="367" height="11" font="3">also  to  the  determinants  of  health,  it  offers  a  road  map  and  tools  for  addressing </text>
<text top="187" left="123" width="367" height="11" font="3">corrupt  action  in  the  health  sector  as  well  as  corruption  affecting  the  social, </text>
<text top="199" left="123" width="367" height="11" font="3">environmental  and  other  determinants  of  health.  Measures  to  address  the  right  to </text>
<text top="211" left="123" width="367" height="11" font="3">health  should  be  holistic  and  integrated,  go  beyond  the  provision  of  health  services </text>
<text top="223" left="123" width="259" height="11" font="3">and be underpinned by cross-departmental commitment (see<a href="https://undocs.org/A/HRC/32/32"> </a></text>
<text top="223" left="383" width="58" height="11" font="21"><a href="https://undocs.org/A/HRC/32/32">A/HRC/32/32</a></text>
<text top="223" left="442" width="49" height="11" font="3"><a href="https://undocs.org/A/HRC/32/32">,</a> para. 37). </text>
<text top="235" left="123" width="367" height="11" font="3">It requires the improvement not only of outcomes but also of processes, for example </text>
<text top="247" left="123" width="367" height="11" font="3">with  governance  and  health  systems  required  to  operate  on  the  basis  of  principles </text>
<text top="259" left="123" width="368" height="11" font="3">including  transparency,  participation,  accountability  and  non-discrimination,  all  of </text>
<text top="271" left="123" width="267" height="11" font="3">which have a particular importance for addressing corruption.  </text>
<text top="289" left="123" width="367" height="11" font="3">27.  In  recent  years,  a  number  of  United  Nations  human  rights  bodies  have </text>
<text top="301" left="123" width="358" height="11" font="3">acknowledged the negative impacts of corruption on the enjoyment of human rights.</text>
<text top="301" left="482" width="6" height="6" font="18">27</text>
<text top="301" left="489" width="2" height="11" font="3"> </text>
<text top="313" left="123" width="367" height="11" font="3">By  its  decision  2002/106,  the  Sub-Commission  on  the  Promotion  and  Protection  of </text>
<text top="325" left="123" width="367" height="11" font="3">Human Rights appointed a Special Rapporteur on the impact of corruption on human </text>
<text top="337" left="123" width="367" height="11" font="3">rights,  in  particular  economic,  social  and  cultural  rights.  In  her  reports,  the  Special </text>
<text top="349" left="123" width="367" height="11" font="3">Rapporteur  established  that  the  enjoyment  of  both  civil  and  political  and  economic, </text>
<text top="361" left="123" width="301" height="11" font="3">social  and  cultural  rights  are  seriously  undermined  by  corruption.</text>
<text top="361" left="426" width="6" height="6" font="18">28</text>
<text top="361" left="432" width="59" height="11" font="3">  In  a  report </text>
<text top="373" left="123" width="367" height="11" font="3">published  in  2015,  the Advisory  Committee  to  the  Human  Rights  Council  explained </text>
<text top="385" left="123" width="367" height="11" font="3">that a human rights perspective on the impact of corruption can move the victims to </text>
<text top="397" left="123" width="368" height="11" font="3">the  centre  of  the  fight  against  corruption  by  highlighting  the  negative  impacts   of </text>
<text top="409" left="123" width="367" height="11" font="3">corruption  on  the  individuals  and  groups  concerned.  The  human  rights  perspective </text>
<text top="421" left="123" width="367" height="11" font="3">also reveals that the State bears the ultimate responsibility for such acts. Establishing </text>
<text top="433" left="123" width="367" height="11" font="3">the  links  between  corruption  and  human  rights  can  promote  access  to  human  rights </text>
<text top="445" left="123" width="367" height="11" font="3">mechanisms to combat corruption, thus creating new opportunities for monitoring and </text>
<text top="457" left="123" width="61" height="11" font="3">litigation (see<a href="https://undocs.org/A/HRC/28/73"> </a></text>
<text top="457" left="184" width="58" height="11" font="21"><a href="https://undocs.org/A/HRC/28/73">A/HRC/28/73</a></text>
<text top="457" left="243" width="98" height="11" font="3"><a href="https://undocs.org/A/HRC/28/73">,</a> paras. 27-28 and 32). </text>
<text top="475" left="123" width="368" height="11" font="3">28.  When it comes to addressing corruption and a lack of transparency, the  right to </text>
<text top="487" left="123" width="367" height="11" font="3">health is closely related to and dependent upon other human rights and fundamental </text>
<text top="499" left="123" width="367" height="11" font="3">freedoms that are critical to the fight against corruption, including the right to life; </text>
<text top="511" left="123" width="368" height="11" font="3">freedom  of  expression  including  the  right  to  seek,  receive  and  impart  info rmation; </text>
<text top="523" left="123" width="239" height="11" font="3">freedom  of  association;  and  the  right  to  a  fair  trial.</text>
<text top="523" left="363" width="6" height="6" font="18">29</text>
<text top="523" left="369" width="122" height="11" font="3">  For  example,  freedom  of </text>
<text top="535" left="123" width="367" height="11" font="3">expression offers a basis for protecting whistle-blowers, which is of key importance </text>
<text top="547" left="123" width="368" height="11" font="3">in combating corruption, while the right to information is vital to access informa tion </text>
<text top="559" left="123" width="367" height="11" font="3">including  on  financial  transactions  and  decision-making  processes  that  may  reveal </text>
<text top="571" left="123" width="367" height="11" font="3">corruption. The promotion and protection of these rights will also therefore be vital </text>
<text top="583" left="123" width="193" height="11" font="3">tools to address corruption affecting health.  </text>
<text top="602" left="123" width="1" height="5" font="8"> </text>
<text top="608" left="123" width="1" height="5" font="8"> </text>
<text top="629" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">25</text>
<text top="643" left="120" width="90" height="8" font="0">  Magdalena Sepúlveda, </text>
<text top="641" left="211" width="253" height="9" font="20"><i>The Nature of the Obligations under the International Covenant on </i></text>
<text top="651" left="123" width="141" height="9" font="20"><i>Economic, Social and Cultural Rights</i></text>
<text top="651" left="265" width="105" height="9" font="0"> (Intersentia, 2003), p. 315. </text>
<text top="664" left="95" width="2" height="8" font="0"> </text>
<text top="662" left="114" width="6" height="5" font="18">26</text>
<text top="664" left="120" width="356" height="8" font="0">  Maureen Lewis, “Governance and Corruption in Public Health Care Systems”, working paper </text>
<text top="672" left="123" width="199" height="9" font="0">No. 78 (Center for Global Development, 2006), p. 8. </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">27</text>
<text top="685" left="120" width="352" height="8" font="0">  Office of the United Nations High Commissioner for Human Rights, “The human rights case </text>
<text top="693" left="123" width="335" height="9" font="0">against corruption”, March 2013. Available from www.ohchr.org/EN/NewsEvents/Pages/ </text>
<text top="704" left="123" width="140" height="9" font="0">HRCaseAgainstCorruption.aspx; and<a href="https://undocs.org/A/HRC/28/73"> </a></text>
<text top="704" left="264" width="51" height="9" font="12"><a href="https://undocs.org/A/HRC/28/73">A/HRC/28/73</a></text>
<text top="704" left="316" width="5" height="9" font="0"><a href="https://undocs.org/A/HRC/28/73">.</a> </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">28</text>
<text top="716" left="120" width="19" height="8" font="0">  See<a href="https://undocs.org/E/CN.4/Sub.2/2004/23"> </a></text>
<text top="714" left="139" width="85" height="9" font="12"><a href="https://undocs.org/E/CN.4/Sub.2/2004/23">E/CN.4/Sub.2/2004/23</a></text>
<text top="714" left="224" width="18" height="9" font="0"><a href="https://undocs.org/E/CN.4/Sub.2/2004/23"> a</a>nd<a href="https://undocs.org/E/CN.4/Sub.2/2005/18"> </a></text>
<text top="714" left="243" width="85" height="9" font="12"><a href="https://undocs.org/E/CN.4/Sub.2/2005/18">E/CN.4/Sub.2/2005/18</a></text>
<text top="714" left="328" width="5" height="9" font="0"><a href="https://undocs.org/E/CN.4/Sub.2/2005/18"> </a> </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">29</text>
<text top="727" left="120" width="206" height="8" font="0">  Toebes, “Human rights and health sector corruption”.  </text>
</page>
<page number="10" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>10/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="76" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="74" left="99" width="362" height="13" font="10"><b>B.  Available, accessible, acceptable and good-quality health care </b></text>
<text top="88" left="123" width="1" height="5" font="8"> </text>
<text top="94" left="123" width="1" height="5" font="8"> </text>
<text top="100" left="123" width="367" height="11" font="3">29.  The  right  to  health  requires  that  health-care  goods,  services  and  facilities  be </text>
<text top="112" left="123" width="367" height="11" font="3">available in adequate numbers; financially and geographically accessible, as well as </text>
<text top="124" left="123" width="367" height="11" font="3">accessible  on  the  basis  of  non-discrimination;  acceptable,  that  is,  respectful  of  the </text>
<text top="136" left="123" width="367" height="11" font="3">culture of individuals,  minorities, peoples and communities and sensitive to gender </text>
<text top="148" left="123" width="367" height="11" font="3">and  life-cycle  requirements  and  of  good  quality,  thus  meeting  all  the  criteria  of </text>
<text top="160" left="123" width="261" height="11" font="3">availability, accessibility, acceptability and quality (AAAQ).</text>
<text top="160" left="385" width="6" height="6" font="18">30</text>
<text top="160" left="392" width="5" height="11" font="3">  </text>
<text top="178" left="123" width="367" height="11" font="3">30.  Petty and grand corruption and institutional and political corruption can have a </text>
<text top="190" left="123" width="367" height="11" font="3">negative impact on the availability, accessibility, acceptability and quality of health </text>
<text top="202" left="123" width="368" height="11" font="3">care.  When  money  that  has  been  allocated  to  the  health  sector  is  embezzled ,  the </text>
<text top="214" left="123" width="229" height="11" font="3">availability of health services and goods is affected.  </text>
<text top="232" left="123" width="367" height="11" font="3">31.  Corruption  can  also  arise  when  States  fail  in  their  obligation  to  ensure  that </text>
<text top="244" left="123" width="367" height="11" font="3">there  is  an  adequate  number  of  health  professionals  receiving  domestically </text>
<text top="256" left="123" width="87" height="11" font="3">competitive  salaries</text>
<text top="256" left="211" width="6" height="6" font="18">31</text>
<text top="256" left="217" width="273" height="11" font="3">  as  petty  corruption  is  often  used  by  health  professionals  or </text>
<text top="268" left="123" width="367" height="11" font="3">other local officials to make up for inadequate, or unpaid salaries, although it should </text>
<text top="280" left="123" width="367" height="11" font="3">also  be  noted  that  bribes  and  illicit  charges  also  occur  where  health  professionals </text>
<text top="292" left="123" width="367" height="11" font="3">earn  adequate  salaries.  As  well  as  competitive  salaries,  reward  for  correct </text>
<text top="304" left="123" width="367" height="11" font="3">performance can also help to tackle corruption. Absenteeism of health service staff </text>
<text top="316" left="123" width="155" height="11" font="3">also negatively affects availability.  </text>
<text top="334" left="123" width="367" height="11" font="3">32.  As  to  physical  accessibility,  health  sector  corruption  can  lead  to  choices  that </text>
<text top="346" left="123" width="368" height="11" font="3">are less favourable to the community, for instance as a result of bribes, health -care </text>
<text top="358" left="123" width="367" height="11" font="3">facilities  may  be  built in  urban or  wealthy  areas  rather than  in  locations  accessible </text>
<text top="370" left="123" width="127" height="11" font="3">to poor or rural populations.  </text>
<text top="388" left="123" width="368" height="11" font="3">33.  In  terms  of  affordability,  health-care  providers  can  make  health-care  services </text>
<text top="400" left="123" width="368" height="11" font="3">more  expensive  by  demanding  payments  (informal  or  under-the-table  payments), </text>
<text top="412" left="123" width="367" height="11" font="3">which can put treatment out of reach and be a  matter of life or death, contribute to </text>
<text top="424" left="123" width="368" height="11" font="3">morbidity  or  impoverish  patients  and  their  families.  The  payment  of  bribes  by </text>
<text top="436" left="123" width="367" height="11" font="3">patients  for  privileged  care  is  common  in  many  countries  and  results  in </text>
<text top="448" left="123" width="367" height="11" font="3">discriminatory  access  to  care,  with  wealthier  patients  likely  to  access  care  more </text>
<text top="460" left="123" width="234" height="11" font="3">easily  than  those  that  are  too  poor  to  pay  bribes.</text>
<text top="460" left="358" width="6" height="6" font="18">32</text>
<text top="460" left="365" width="126" height="11" font="3">  As  a  result  of  bribery  in </text>
<text top="472" left="123" width="260" height="11" font="3">procurement processes, medicines may be more expensive.  </text>
<text top="490" left="123" width="367" height="11" font="3">34.  In terms of information accessibility, a lack of information about rights in the </text>
<text top="502" left="123" width="367" height="11" font="3">health  system  can  provide  a  smokescreen  for  corruption.  Moreover,  patients  are </text>
<text top="514" left="123" width="368" height="11" font="3">vulnerable  due  to  the  so-called  “information  imbalance”  in  the  health  sector,  with </text>
<text top="526" left="123" width="367" height="11" font="3">doctors being  more knowledgeable about the health-care services that they provide </text>
<text top="538" left="123" width="84" height="11" font="3">than the receivers.  </text>
<text top="556" left="123" width="367" height="11" font="3">35.  Corruption also infringes medical ethics, which are an essential component of </text>
<text top="568" left="123" width="367" height="11" font="3">acceptable  health  care.  Lastly, in  terms  of  quality,  corruption  can  affect the  quality </text>
<text top="580" left="123" width="367" height="11" font="3">of  medicines,  for  example,  when  regulators  are  bribed  to  carry  out  less  rigorous </text>
<text top="592" left="123" width="358" height="11" font="3">checks,  or  when  hospital  administrators  purchase  medicines  of  unknown  quality.</text>
<text top="592" left="482" width="6" height="6" font="18">33</text>
<text top="592" left="489" width="2" height="11" font="3"> </text>
<text top="604" left="123" width="367" height="11" font="3">Quality can also be compromised where bribes are extorted or accepted in decisions </text>
<text top="616" left="123" width="275" height="11" font="3">on hiring staff, or accrediting, licensing or certifying facilities,</text>
<text top="616" left="400" width="6" height="6" font="18">34</text>
<text top="616" left="406" width="85" height="11" font="3"> in deciding  which </text>
<text top="639" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">30</text>
<text top="653" left="120" width="369" height="8" font="0">  Committee on Economic, Social and Cultural Rights, general comment No. 14, para. 12. See also </text>
<text top="662" left="123" width="35" height="9" font="12"><a href="https://undocs.org/A/71/304">A/71/304</a></text>
<text top="662" left="158" width="40" height="9" font="0"><a href="https://undocs.org/A/71/304">, </a>para. 17. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">31</text>
<text top="674" left="120" width="350" height="8" font="0">  Committee on Economic, Social and Cultural Rights, general comment No. 14 , para. 12 (a). </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">32</text>
<text top="685" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="683" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="683" left="348" width="28" height="9" font="0">, p. 10. </text>
<text top="695" left="95" width="2" height="8" font="0"> </text>
<text top="693" left="114" width="6" height="5" font="18">33</text>
<text top="695" left="120" width="303" height="8" font="0">  Brigit Toebes, “Health Sector Corruption and Human Righ ts: A Case Study”, in </text>
<text top="693" left="423" width="60" height="9" font="20"><i>Corruption and </i></text>
<text top="704" left="123" width="171" height="9" font="20"><i>Human Rights: Interdisciplinary Perspectives</i></text>
<text top="704" left="295" width="157" height="9" font="0">, Martine Boersma and Hans Nelen (eds.) </text>
<text top="714" left="123" width="235" height="9" font="0">(Antwerp/Cambridge/Portland, Intersentia, 2010), pp. 91-123. </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">34</text>
<text top="727" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="725" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="725" left="348" width="36" height="9" font="0">, p. xviii. </text>
</page>
<page number="11" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>11/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="234" height="11" font="3">medicines  to  include  on  essential  medicines  lists,</text>
<text top="73" left="358" width="6" height="6" font="18">35</text>
<text top="73" left="365" width="126" height="11" font="3">  or  to  market  unregulated </text>
<text top="85" left="123" width="345" height="11" font="3">medicines,  which  can  increase  mortality  and  morbidity  among  those  affected,</text>
<text top="85" left="469" width="6" height="6" font="18">36</text>
<text top="85" left="476" width="16" height="11" font="3">  as </text>
<text top="97" left="123" width="367" height="11" font="3">well  as  hampering  disease  control  efforts.  Nepotism,  cronyism  and  other  forms  of </text>
<text top="109" left="123" width="356" height="11" font="3">favouritism can also compromise the quality of health and health -related services. </text>
<text top="127" left="123" width="368" height="11" font="3">36.  The right to health requires that States take action, including poli cy, legislative </text>
<text top="139" left="123" width="368" height="11" font="3">and budgetary action, to prevent corruption from impeding the available,  accessible, </text>
<text top="151" left="123" width="177" height="11" font="3">acceptable and good-quality health care. </text>
<text top="170" left="123" width="1" height="5" font="8"> </text>
<text top="176" left="123" width="1" height="5" font="8"> </text>
<text top="183" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="181" left="99" width="339" height="13" font="10"><b>C.  Underlying and social determinants of the right to health </b></text>
<text top="195" left="123" width="1" height="5" font="8"> </text>
<text top="201" left="123" width="1" height="5" font="8"> </text>
<text top="207" left="123" width="367" height="11" font="3">37.  Corruption  compromises  the  ability  of  the  State  to  guarantee  the  underlying </text>
<text top="219" left="123" width="367" height="11" font="3">and social determinants of health including safe drinking  water, safe and nutritious </text>
<text top="231" left="123" width="367" height="11" font="3">food and a healthy environment, and exacerbates the discrimination and inequalities </text>
<text top="243" left="123" width="202" height="11" font="3">that prevail in societies throughout the world.  </text>
<text top="261" left="123" width="367" height="11" font="3">38.  To take the example of water, around 10 per cent of water sector investment is </text>
<text top="273" left="123" width="367" height="11" font="3">lost  to  corruption.  Corruption  can  make  water  inaccessible  and  unaffordable  and </text>
<text top="285" left="123" width="367" height="11" font="3">affect  the  quality  of  water.  In  some  low-income  countries,  corruption  can  add  an </text>
<text top="297" left="123" width="336" height="11" font="3">estimated  30-45  per  cent  to  the  price  of  connection  to  a  water  network.</text>
<text top="297" left="460" width="6" height="6" font="18">37</text>
<text top="297" left="467" width="24" height="11" font="3">  The </text>
<text top="309" left="123" width="367" height="11" font="3">increasing role played by private sector actors in water services requires the State to </text>
<text top="321" left="123" width="191" height="11" font="3">adopt an appropriate regulatory framework. </text>
<text top="339" left="123" width="368" height="11" font="3">39.  The  harmful  effects  of  the  tobacco  industry  and  unhealthy  foods  industry  has </text>
<text top="351" left="123" width="367" height="11" font="3">been  covered  up  by  manufacturers  and  industry  lobbyists,  including  through </text>
<text top="363" left="123" width="367" height="11" font="3">sponsoring research to downplay links to health problems. Misinformation, pressure </text>
<text top="375" left="123" width="365" height="11" font="3">and bribery from private sector actors, including the food and beverage  and breast-</text>
<text top="387" left="123" width="116" height="11" font="3">milk  substitute  industries</text>
<text top="387" left="240" width="6" height="6" font="18">38</text>
<text top="387" left="246" width="244" height="11" font="3">  and  the  tobacco  and  the  polluting  industries,  can </text>
<text top="399" left="123" width="367" height="11" font="3">interfere  with  the  obligation  of  governments  to  adopt  an  appropriate  legislative, </text>
<text top="411" left="123" width="310" height="11" font="3">regulatory and policy framework to promote and protect public health.   </text>
<text top="429" left="123" width="367" height="11" font="3">40.  Discrimination  encompasses  any  distinction,  exclusion  or  restriction  that  has </text>
<text top="441" left="123" width="367" height="11" font="3">the  purpose  or  effect  of  nullifying  or  impairing  the  recognition,  enjoyment  or </text>
<text top="453" left="123" width="367" height="11" font="3">exercise  by  all  persons,  on  an  equal  footing,  of  all  rights  and  freedoms. </text>
<text top="465" left="123" width="368" height="11" font="3">Non-discrimination  and  equality  are  human  rights  obligations  which  are </text>
<text top="477" left="123" width="367" height="11" font="3">fundamental  to  realizing  the  right  to  health.  Not  only  must  health  and  other  goods </text>
<text top="489" left="123" width="368" height="11" font="3">and  services  be  available  to  all  on  the  basis  of  non-discrimination,  but  broader </text>
<text top="501" left="123" width="368" height="11" font="3">promotion  and  protection  of  equality  and  non-discrimination  are  vital  in </text>
<text top="513" left="123" width="261" height="11" font="3">guaranteeing the equitable enjoyment of the right to health.   </text>
<text top="531" left="123" width="367" height="11" font="3">41.  There  is  ample  research  indicating  that  corruption  and  a  lack  of  transparency </text>
<text top="543" left="123" width="367" height="11" font="3">exacerbate  socioeconomic  deprivation.  Lower  social  groups  carry  a  heavier  burden </text>
<text top="555" left="123" width="168" height="11" font="3">in a society rife with corrupt elements.</text>
<text top="555" left="292" width="6" height="6" font="18">39</text>
<text top="555" left="299" width="192" height="11" font="3"> In turn, the equal enjoyment of the right to </text>
<text top="567" left="123" width="254" height="11" font="3">health is deeply affected by poverty and income inequality.</text>
<text top="567" left="378" width="6" height="6" font="18">40</text>
<text top="567" left="385" width="5" height="11" font="3">  </text>
<text top="585" left="123" width="367" height="11" font="3">42.  In the health sector, low-income and other groups in vulnerable situations are </text>
<text top="597" left="123" width="368" height="11" font="3">affected  the  most  by  corruption  and  a  lack  of  transparency.  Lower-income  groups </text>
<text top="618" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="632" left="95" width="2" height="8" font="0"> </text>
<text top="630" left="114" width="6" height="5" font="18">35</text>
<text top="632" left="120" width="107" height="8" font="0">  Mostert and others, p. 396. </text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">36</text>
<text top="643" left="120" width="362" height="8" font="0">  U4 Anti-Corruption Resource Centre, “Corruption in the health sector”, U4 issue 2008 , No. 10, </text>
<text top="651" left="123" width="23" height="9" font="0">p. 18. </text>
<text top="664" left="95" width="2" height="8" font="0"> </text>
<text top="662" left="114" width="6" height="5" font="18">37</text>
<text top="664" left="120" width="19" height="8" font="0">  See<a href="https://www.transparency.org/topic/detail/water"> </a></text>
<text top="662" left="139" width="177" height="9" font="12"><a href="https://www.transparency.org/topic/detail/water">https://www.transparency.org/topic/detail/water</a></text>
<text top="662" left="317" width="5" height="9" font="0"><a href="https://www.transparency.org/topic/detail/water">. </a></text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">38</text>
<text top="674" left="120" width="19" height="8" font="0">  Se<a href="https://undocs.org/A/HRC/32/32">e </a></text>
<text top="672" left="139" width="51" height="9" font="12"><a href="https://undocs.org/A/HRC/32/32">A/HRC/32/32</a></text>
<text top="672" left="190" width="284" height="9" font="0"><a href="https://undocs.org/A/HRC/32/32"> a</a>nd joint statement by the Special Rapporteur and others on breastfeeding. </text>
<text top="683" left="123" width="58" height="9" font="0">Available from<a href="http://www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=20871&amp;LangID=E"> </a></text>
<text top="683" left="182" width="279" height="9" font="12"><a href="http://www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=20871&amp;LangID=E">www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=20871 </a></text>
<text top="693" left="123" width="46" height="9" font="12"><a href="http://www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=20871&amp;LangID=E">&amp;LangID=E</a></text>
<text top="693" left="170" width="5" height="9" font="0"><a href="http://www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=20871&amp;LangID=E">.</a> </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">39</text>
<text top="706" left="120" width="113" height="8" font="0">  Witvliet and others, p. 1246. </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">40</text>
<text top="716" left="120" width="351" height="8" font="0">  Committee on Economic, Social and Cultural Rights, general comment No. 22 (2016) on the </text>
<text top="725" left="123" width="180" height="9" font="0">right to sexual and reproductive health, para. 8. </text>
</page>
<page number="12" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>12/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">have  the  most  difficulty  affording  the informal  payments that  are often required  to </text>
<text top="85" left="123" width="368" height="11" font="3">receive  the  medical  treatment  they  need.  In  health-care  settings  that  face  a  high </text>
<text top="97" left="123" width="367" height="11" font="3">level of corruption, the poorer sections of the population and those who live in rural </text>
<text top="109" left="123" width="367" height="11" font="3">areas  may  suffer  longer  waiting  periods  at  public  health  clinics  and  are  also  more </text>
<text top="121" left="123" width="325" height="11" font="3">frequently denied  vaccines than rich and urban sections of the population.</text>
<text top="121" left="450" width="6" height="6" font="18">41</text>
<text top="121" left="456" width="35" height="11" font="3">  Health </text>
<text top="133" left="123" width="368" height="11" font="3">sector  corruption  can  also  lead  to  discrimination  more  directly  when  health -care </text>
<text top="145" left="123" width="367" height="11" font="3">providers  and  professionals treat  patients differently  according to  their  income and </text>
<text top="157" left="123" width="184" height="11" font="3">their contact with the medical profession.  </text>
<text top="175" left="123" width="367" height="11" font="3">43.  There are several intersecting groups in society that suffer from corruption on </text>
<text top="187" left="123" width="367" height="11" font="3">other grounds. There is, for example, evidence that corruption does not affect rural </text>
<text top="199" left="123" width="368" height="11" font="3">areas  in  the  same  way  as  it  affects  urban  areas.  Women  can  often  be  particularly </text>
<text top="211" left="123" width="367" height="11" font="3">affected by health sector corruption. In many countries, they are more likely to use </text>
<text top="223" left="123" width="367" height="11" font="3">health  care  than  men,  a  pattern  partly  explained  by  their  increased  use  of  services </text>
<text top="235" left="123" width="368" height="11" font="3">during their reproductive years. They may thus be disproportionately affe cted by the </text>
<text top="247" left="123" width="367" height="11" font="3">effects of health sector corruption, for example when they lack the money to afford </text>
<text top="259" left="123" width="367" height="11" font="3">informal  payments  necessary  for assistance  around childbirth. Women  may  also  be </text>
<text top="271" left="123" width="367" height="11" font="3">more  vulnerable  to  informal  payments  where  they  lack  economic  means,  for </text>
<text top="283" left="123" width="367" height="11" font="3">example  where  they  do  not  participate  equally  in  the  paid  labour  force  or  do  not </text>
<text top="295" left="123" width="367" height="11" font="3">have  equal  access  to  or  control  of  financial  resources  within  the  household. </text>
<text top="307" left="123" width="368" height="11" font="3">Furthermore, women constitute a large proportion of health-care personnel, and can </text>
<text top="319" left="123" width="367" height="11" font="3">thus be disproportionately affected when health sector corruption negatively affects </text>
<text top="331" left="123" width="157" height="11" font="3">the timely payment of proper wages.</text>
<text top="331" left="281" width="6" height="6" font="18">42</text>
<text top="331" left="288" width="5" height="11" font="3">  </text>
<text top="350" left="123" width="1" height="5" font="8"> </text>
<text top="356" left="123" width="1" height="5" font="8"> </text>
<text top="363" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="361" left="99" width="283" height="13" font="10"><b>D.  Participation, transparency and accountability </b></text>
<text top="375" left="123" width="1" height="5" font="8"> </text>
<text top="381" left="123" width="1" height="5" font="8"> </text>
<text top="387" left="123" width="367" height="11" font="3">44.  Meaningful  participation  of  people  in  decisions  that  affect  their  health  and </text>
<text top="399" left="123" width="367" height="11" font="3">socioeconomic  well-being  is  a  key  component  of  the  right  to  health  and  crucial </text>
<text top="411" left="123" width="367" height="11" font="3">when it comes to combating corruption in health care and in society at large. States’ </text>
<text top="423" left="123" width="367" height="11" font="3">obligations under article 12 of the International Covenant on Economic, Social and </text>
<text top="435" left="123" width="368" height="11" font="3">Cultural  Rights  require  that  the  right  to  participate  in  decision-making  processes </text>
<text top="447" left="123" width="367" height="11" font="3">affecting  their  health  and  development  must  be  an  integral  component  of  any </text>
<text top="459" left="123" width="171" height="11" font="3">relevant policy, programme  or strategy.</text>
<text top="459" left="295" width="6" height="6" font="18">43</text>
<text top="459" left="301" width="190" height="11" font="3"> Sustainable Development Goal target 16.7 </text>
<text top="471" left="123" width="367" height="11" font="3">stipulates  the  duty  to  ensure  responsive,  inclusive,  participatory  and  representative </text>
<text top="483" left="123" width="132" height="11" font="3">decision-making at all levels.  </text>
<text top="501" left="123" width="367" height="11" font="3">45.  Participation in health decision-making leads to improved health outcomes and </text>
<text top="513" left="123" width="367" height="11" font="3">is  essential  for  ensuring  the  distribution  of  policies  and  programmes  to  broader </text>
<text top="525" left="123" width="367" height="11" font="3">segments  of  the  population,  thus  making  governance  more  accountable. </text>
<text top="537" left="123" width="367" height="11" font="3">Participation goes beyond merely being educated, informed or consulted. It implies </text>
<text top="549" left="123" width="367" height="11" font="3">a  human  right  to  actively  engage  individuals  and  groups  in  the  development, </text>
<text top="561" left="123" width="367" height="11" font="3">implementation  and  review  of  policies,  standards,  indicators,  benchmarks  or </text>
<text top="573" left="123" width="368" height="11" font="3">legislation, particularly aimed at including the voices and needs of mor e vulnerable </text>
<text top="585" left="123" width="287" height="11" font="3">or otherwise underrepresented and especially affected populations.</text>
<text top="585" left="411" width="6" height="6" font="18">44</text>
<text top="585" left="418" width="5" height="11" font="3">  </text>
<text top="603" left="123" width="368" height="11" font="3">46.  Key  elements  of  meaningful  participation  with  the  aim  of  preventing   and </text>
<text top="615" left="123" width="368" height="11" font="3">controlling  corruption  are  the  active  disclosure  of  important  health -related </text>
<text top="629" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">41</text>
<text top="643" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="641" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="641" left="348" width="45" height="9" font="0">, pp. 37-39. </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">42</text>
<text top="653" left="120" width="256" height="8" font="0">  Toebes, “Human rights and health sector corruption”, pp. 106 -134. </text>
<text top="664" left="95" width="2" height="8" font="0"> </text>
<text top="662" left="114" width="6" height="5" font="18">43</text>
<text top="664" left="120" width="19" height="8" font="0">  Se<a href="https://undocs.org/A/HRC/32/32">e </a></text>
<text top="662" left="139" width="51" height="9" font="12"><a href="https://undocs.org/A/HRC/32/32">A/HRC/32/32</a></text>
<text top="662" left="190" width="273" height="9" font="0"><a href="https://undocs.org/A/HRC/32/32">, </a>para. 53; see also Committee on Economic, Social and Cultural Rights, </text>
<text top="672" left="123" width="131" height="9" font="0">general comment No. 14, para. 11. </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">44</text>
<text top="685" left="120" width="363" height="8" font="0">  See also Helen Potts, “Participation and the Human Right to the Highest Attainable Standard of </text>
<text top="693" left="123" width="282" height="9" font="0">Health” (University of Essex, Human Rights Centre, 2007), available from </text>
<text top="704" left="123" width="350" height="9" font="12"><a href="http://repository.essex.ac.uk/9714/1/participation-right-highest-attainable-standard-health.pdf">http://repository.essex.ac.uk/9714/1/participation-right-highest-attainable-standard-health.pdf</a></text>
<text top="704" left="474" width="5" height="9" font="0"><a href="http://repository.essex.ac.uk/9714/1/participation-right-highest-attainable-standard-health.pdf">;</a> </text>
<text top="714" left="123" width="234" height="9" font="0">Marlies Hesselman, Antenor Hallo de Wolf and Brigit Toebes, </text>
<text top="714" left="358" width="128" height="9" font="20"><i>Socio-Economic Human Rights in </i></text>
<text top="725" left="123" width="132" height="9" font="20"><i>Essential Public Services Provision</i></text>
<text top="725" left="256" width="103" height="9" font="0"> (Routledge, 2017), p. 317. </text>
</page>
<page number="13" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>13/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="365" height="11" font="3">information  and  the  participation  of  relevant  stakeholders  in  health  decision-</text>
<text top="85" left="123" width="367" height="11" font="3">making, including in health sector plans, in the annual budget process and in review </text>
<text top="97" left="123" width="235" height="11" font="3">processes  for  health  laws,  policies  and  programmes.</text>
<text top="97" left="360" width="6" height="6" font="18">45</text>
<text top="97" left="366" width="125" height="11" font="3">  In  the  context  of  budgets, </text>
<text top="109" left="123" width="367" height="11" font="3">participation  involves  the  engagement  of  a  variety  of  stakeholders  in  determining </text>
<text top="121" left="123" width="367" height="11" font="3">the allocation of funding, as  well as  monitoring expenditure. Methods for realizing </text>
<text top="133" left="123" width="367" height="11" font="3">participation  include  forums  and  conferences,  local  health  committees  and  teams, </text>
<text top="145" left="123" width="367" height="11" font="3">citizens’ juries, public  meetings,  but  also  institutional  participation,  for  example in </text>
<text top="157" left="123" width="69" height="11" font="3">hospital  boards.</text>
<text top="157" left="193" width="6" height="6" font="18">46</text>
<text top="157" left="199" width="291" height="11" font="3">  Key  stakeholders  include,  but  are  not  limited  to,  national  health </text>
<text top="169" left="123" width="367" height="11" font="3">assemblies,  community-based  and  grass-roots  organizations,  professional </text>
<text top="181" left="123" width="347" height="11" font="3">associations and other non-governmental bodies and civil society organizations. </text>
<text top="199" left="123" width="367" height="11" font="3">47.  Patients’  organizations  and  other  more  empowered  interest  groups  may  exert </text>
<text top="211" left="123" width="367" height="11" font="3">influence  on  health  decision-making  by  lobbying  in  favour  of  the  prescription  and </text>
<text top="223" left="123" width="367" height="11" font="3">reimbursement  of  expensive  drugs  or  particular  programmes  or  treatments  in  a </text>
<text top="235" left="123" width="367" height="11" font="3">health  service  at  the  expense  of  other  treatments  or  programmes.  Paradoxically, </text>
<text top="247" left="123" width="368" height="11" font="3">these activities can  reinforce imbalances  and power  asymmetries,  a s they too  often </text>
<text top="259" left="123" width="367" height="11" font="3">result  in  undue  pressure  on  policymakers  to  invest  in  specialized  care  and  vertical </text>
<text top="271" left="123" width="367" height="11" font="3">programmes  of  treatment  for  certain  diseases  at  the  expense  of  primary  care  and </text>
<text top="283" left="123" width="368" height="11" font="3">holistic  medicine.  Thus  participation  has  to  be  carefully  planned,  balanced   and </text>
<text top="295" left="123" width="367" height="11" font="3">accompanied by open and transparent planning mechanisms to ensure representation </text>
<text top="307" left="123" width="261" height="11" font="3">of a broad range of civil society and other key stakeholders.  </text>
<text top="325" left="123" width="367" height="11" font="3">48.  Where  there  is  opacity  surrounding  decisions  at  the  political,  macro  or  micro </text>
<text top="337" left="123" width="367" height="11" font="3">levels,  corruption  can  flourish,  go  undetected  and  occur  with  impunity. </text>
<text top="349" left="123" width="367" height="11" font="3">Transparency  unveils  corruption  and  is  inextricably  linked  to  the  right  to  access </text>
<text top="361" left="123" width="367" height="11" font="3">information,  participation  and  accountability.  Access  to  information  and </text>
<text top="373" left="123" width="368" height="11" font="3">transparency  laws  provide  a  framework  for  addressing  corrupt  practices,  while  the </text>
<text top="385" left="123" width="367" height="11" font="3">regulations  and  monitoring  arrangements  are  also  vital.  Transparency  can  often  be </text>
<text top="397" left="123" width="367" height="11" font="3">enhanced  by  the  participation  of  rights  holders  and  civil  society  organizations  in </text>
<text top="409" left="123" width="290" height="11" font="3">decision-making processes that may be prone to corrupt practices.  </text>
<text top="427" left="123" width="367" height="11" font="3">49.  There  are  particular  challenges  to  transparency  in  the  health  sector. </text>
<text top="439" left="123" width="367" height="11" font="3">Asymmetric  information  between  providers,  payers  and  users  leads  to  provider  or </text>
<text top="451" left="123" width="367" height="11" font="3">user  moral  hazard.  Information  is  divided  between  a  multitude  of  different  actors, </text>
<text top="463" left="123" width="367" height="11" font="3">including  regulators,  payers,  providers,  users  and  suppliers,  which  reduces </text>
<text top="475" left="123" width="367" height="11" font="3">transparency. There  are  many  varying  ways  to  improve  transparency  depending  on </text>
<text top="487" left="123" width="367" height="11" font="3">the  context.  For  example,  transparency  in  procurement  is  enhanced  through  public </text>
<text top="499" left="123" width="367" height="11" font="3">access to procurement bidding results, monitoring of the prices paid and analysis of </text>
<text top="511" left="123" width="20" height="11" font="3">bids.</text>
<text top="511" left="144" width="6" height="6" font="18">47</text>
<text top="511" left="151" width="340" height="11" font="3">  Transparency  in  recruitment  can  be  supported  through  the  publication  of </text>
<text top="523" left="123" width="367" height="11" font="3">criteria.  Transparency  through  the  promotion  of  information  that  sets  out  the </text>
<text top="535" left="123" width="367" height="11" font="3">services and treatments to which individuals are entitled and how these services are </text>
<text top="547" left="123" width="367" height="11" font="3">reimbursed  can  help  minimize  inequalities  in  access  to  care  through  corrupt </text>
<text top="559" left="123" width="367" height="11" font="3">practices.  The  publication  of  transparent  waiting  lists  can  negate  the  practice  of </text>
<text top="571" left="123" width="171" height="11" font="3">bribery to access more rapid treatment. </text>
<text top="589" left="123" width="367" height="11" font="3">50.  There  is  a  significant  demand  from  civil  society  for  accountability  of </text>
<text top="601" left="123" width="156" height="11" font="3">Governments  and  other  institutions.</text>
<text top="601" left="281" width="6" height="6" font="18">48</text>
<text top="601" left="287" width="204" height="11" font="3">  Sustainable  Development  Goal 16  includes  a </text>
<text top="613" left="123" width="367" height="11" font="3">commitment  to  create  effective,  transparent  and  accountable  institutions  at  all </text>
<text top="625" left="123" width="367" height="11" font="3">levels. Accountability is at the heart of human rights and central to the fight against </text>
<text top="637" left="123" width="367" height="11" font="3">corruption.  Human  rights-based  accountability  for  corruption  helps  reveal  where </text>
<text top="660" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">45</text>
<text top="674" left="120" width="354" height="8" font="0">  U4 Anti-Corruption Resource Centre, “Addressing corruption in the health sector”,  U4 issue, </text>
<text top="683" left="123" width="80" height="9" font="0">January 2011, No. 1. </text>
<text top="695" left="95" width="2" height="8" font="0"> </text>
<text top="693" left="114" width="6" height="5" font="18">46</text>
<text top="695" left="120" width="363" height="8" font="0">  Potts, “Participation and the Human Right to the Highest Attainable Standard of Health”, p. 20.  </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">47</text>
<text top="706" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="704" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="704" left="348" width="28" height="9" font="0">, p. 59. </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">48</text>
<text top="716" left="120" width="370" height="8" font="0">  Independent Accountability Panel, “2016: old challenges, new hope: accountability for the global </text>
<text top="725" left="123" width="265" height="9" font="0">strategy for women’s, children’s and adolescents’ health” (2016), p. 7. </text>
</page>
<page number="14" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>14/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">corruption  has  taken  place  and  resulted  in  human  rights  abuses.  Effective </text>
<text top="85" left="123" width="368" height="11" font="3">accountability  processes  are  also  important  for  the  reason  that  they  can  have  a </text>
<text top="97" left="123" width="367" height="11" font="3">deterrent  effect  in  relation  to  corruption.  It  is  therefore  troubling  that  research </text>
<text top="109" left="123" width="245" height="11" font="3">suggests  that  accountability  for  corruption  is  rare,</text>
<text top="109" left="369" width="6" height="6" font="18">49</text>
<text top="109" left="376" width="115" height="11" font="3">  indicating  a  need  for </text>
<text top="121" left="123" width="368" height="11" font="3">governments  to  take  concerted  steps  to  strengthen  accountability  mechanis ms  and </text>
<text top="133" left="123" width="47" height="11" font="3">processes. </text>
<text top="151" left="123" width="367" height="11" font="3">51.  Accountability  comprises  three  elements:  monitoring  (“what  is  happening, </text>
<text top="163" left="123" width="367" height="11" font="3">where  and  to  whom  (results)  and  how  much  is  spent,  where,  on  what  and  whom </text>
<text top="175" left="123" width="367" height="11" font="3">(resources)”), review (“analysing whether pledges, promises and commitments have </text>
<text top="187" left="123" width="237" height="11" font="3">been  kept  by  countries,  donors  and  non-state  actors”)</text>
<text top="187" left="361" width="6" height="6" font="18">50</text>
<text top="187" left="367" width="114" height="11" font="3">  and  remedies  and  action.</text>
<text top="187" left="482" width="6" height="6" font="18">51</text>
<text top="187" left="489" width="2" height="11" font="3"> </text>
<text top="199" left="123" width="365" height="11" font="3">The  rule  of  law,  transparency  and  access  to  information,  including  on  decision -</text>
<text top="211" left="123" width="367" height="11" font="3">making  processes,  budgets  and  financial  transfers  in  both  the  public  and  private </text>
<text top="223" left="123" width="316" height="11" font="3">sectors, provide vital conditions which help to strengthen accountability. </text>
<text top="241" left="123" width="367" height="11" font="3">52.  Health  systems  are  complex  and  a  wide  range  of  monitoring  and  review </text>
<text top="253" left="123" width="367" height="11" font="3">processes  have  a  role  to  play  in  enhancing  accountability  for  the  right  to  health  in </text>
<text top="265" left="123" width="367" height="11" font="3">the context of corruption. In terms of  monitoring, budget  monitoring, effective and </text>
<text top="277" left="123" width="367" height="11" font="3">accurate  accounting,  audits  and  public  expenditure  tracking  surveys  are  ways  of </text>
<text top="289" left="123" width="367" height="11" font="3">monitoring  how  funds  have  been  allocated  and  whether  they  have  been  distributed </text>
<text top="301" left="123" width="368" height="11" font="3">as  intended,  or  whether  corruption  may  have  occurred.  Yet  in  many  low-income </text>
<text top="313" left="123" width="367" height="11" font="3">countries,  Governments  lack  financial  and  technical  capacity  to  operate  such </text>
<text top="325" left="123" width="123" height="11" font="3">systems in an effective way.</text>
<text top="325" left="247" width="6" height="6" font="18">52</text>
<text top="325" left="253" width="237" height="11" font="3"> As well as monitoring of funds, monitoring of health </text>
<text top="337" left="123" width="365" height="11" font="3">professionals’  practice  and  supplies  is  also  important.  The  establishment  of  well-</text>
<text top="349" left="123" width="367" height="11" font="3">resourced and independent anti-corruption and fraud agencies to prevent and detect </text>
<text top="361" left="123" width="367" height="11" font="3">corruption, including in the health sector, can also support the monitoring dimension </text>
<text top="373" left="123" width="74" height="11" font="3">of accountability.</text>
<text top="373" left="198" width="6" height="6" font="18">53</text>
<text top="373" left="205" width="5" height="11" font="3">  </text>
<text top="391" left="123" width="368" height="11" font="3">53.  Judicial,  quasi-judicial,  political  and  administrative  mechanisms  at  the  local, </text>
<text top="403" left="123" width="335" height="11" font="3">national  and  international  levels  can  all  play  an  important  review  function.</text>
<text top="403" left="460" width="6" height="6" font="18">54</text>
<text top="403" left="466" width="25" height="11" font="3">  It  is </text>
<text top="415" left="123" width="367" height="11" font="3">essential  that  rights  holders  are  aware  of  their  entitlements  and  that  complaints </text>
<text top="427" left="123" width="368" height="11" font="3">procedures are simple and accessible. Independent complaints pro cedures are often </text>
<text top="439" left="123" width="367" height="11" font="3">valuable. Rights holders must be able to participate in review procedures carried out </text>
<text top="451" left="123" width="368" height="11" font="3">by  quasi-judicial,  political  or  administrative  bodies.  Moreover,  whistle-blower </text>
<text top="463" left="123" width="368" height="11" font="3">protection  in  the  public  and  private  sectors  for  individuals  in  procurement  bodies, </text>
<text top="475" left="123" width="367" height="11" font="3">health authorities, health service providers and suppliers of medicine and equipment </text>
<text top="487" left="123" width="281" height="11" font="3">supports review through encouraging the reporting of corruption.</text>
<text top="487" left="406" width="6" height="6" font="18">55</text>
<text top="487" left="412" width="79" height="11" font="3"> Domestic human </text>
<text top="499" left="123" width="368" height="11" font="3">rights  bodies,  such  as  national  human  rights  institutions,  as  well  as  internat ional </text>
<text top="511" left="123" width="367" height="11" font="3">mechanisms  such  as  the  United  Nations  treaty  bodies  and  the  universal  periodic </text>
<text top="523" left="123" width="367" height="11" font="3">review,  can  provide  an  important  contribution  to  enhancing  accountability  for  the </text>
<text top="535" left="123" width="233" height="11" font="3">right to health, including in the context of corruption. </text>
<text top="553" left="123" width="367" height="11" font="3">54.  Governments  must  take  action  where  monitoring  and  review  have  revealed </text>
<text top="565" left="123" width="367" height="11" font="3">corrupt practices.  Not  only  should  sanctions be  applied, but  remedies  must also be </text>
<text top="577" left="123" width="367" height="11" font="3">awarded and implemented. Accountability should not be exclusively equated with a </text>
<text top="589" left="123" width="367" height="11" font="3">blame and punishment model that puts front-line workers in the firing line. Rather it </text>
<text top="601" left="123" width="367" height="11" font="3">is  better  understood  as  reinforcing  the  rule  of  law,  including  the  promotion  and </text>
<text top="613" left="123" width="367" height="11" font="3">protection  of  the  right  to  health  in  the  health  system.  Court  judgments,  as  well  as </text>
<text top="629" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">49</text>
<text top="643" left="120" width="320" height="8" font="0">  Lewis, “Governance and Corruption in Public Health Care Systems”, pp. 20 and 40.  </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">50</text>
<text top="653" left="120" width="321" height="8" font="0">  Commission on Information and Accountability for Women’s and Children’s Health, </text>
<text top="651" left="442" width="33" height="9" font="20"><i>Keeping </i></text>
<text top="662" left="123" width="108" height="9" font="20"><i>Promises, Measuring Results</i></text>
<text top="662" left="232" width="24" height="9" font="0">, p. 7. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">51</text>
<text top="674" left="120" width="293" height="8" font="0">  Independent Accountability Panel, “2016: old challenges, new hope s”, p. 12. </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">52</text>
<text top="685" left="120" width="297" height="8" font="0">  U4 Anti-Corruption Resource Centre, “Corruption in the health sector”, p. 11.  </text>
<text top="695" left="95" width="2" height="8" font="0"> </text>
<text top="693" left="114" width="6" height="5" font="18">53</text>
<text top="695" left="120" width="109" height="8" font="0">  Transparency International, </text>
<text top="693" left="229" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="693" left="348" width="35" height="9" font="0">, p. XXI. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">54</text>
<text top="706" left="120" width="51" height="8" font="0">  Helen Potts, </text>
<text top="704" left="172" width="276" height="9" font="20"><i>Accountability and the Right to the Highest Attainable Standard of Health</i></text>
<text top="704" left="449" width="2" height="9" font="0"> </text>
<text top="714" left="123" width="108" height="9" font="0">(University of Essex, 2008). </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">55</text>
<text top="727" left="120" width="124" height="8" font="0">  See Transparency International, </text>
<text top="725" left="245" width="118" height="9" font="20"><i>Global Corruption Report 2006</i></text>
<text top="725" left="363" width="32" height="9" font="0">, p. XX. </text>
</page>
<page number="15" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>15/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="368" height="11" font="3">recommendations from other review bodies, can lead to  actions by governments and </text>
<text top="85" left="123" width="313" height="11" font="3">other duty bearers producing transformative changes in the health sector.</text>
<text top="85" left="438" width="6" height="6" font="18">56</text>
<text top="85" left="444" width="5" height="11" font="3">  </text>
<text top="104" left="123" width="1" height="5" font="8"> </text>
<text top="110" left="123" width="1" height="5" font="8"> </text>
<text top="117" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="115" left="99" width="266" height="13" font="10"><b>E.  Role and responsibilities of non-state actors </b></text>
<text top="129" left="123" width="1" height="5" font="8"> </text>
<text top="135" left="123" width="1" height="5" font="8"> </text>
<text top="141" left="123" width="367" height="11" font="3">55.  Under the  Universal  Declaration of  Human  Rights,  all  organs  of  society  have </text>
<text top="153" left="123" width="367" height="11" font="3">human  rights  responsibilities.  It  is  now  widely  acknowledged  that,  while  States </text>
<text top="165" left="123" width="367" height="11" font="3">parties  are  ultimately  accountable  for  the  right  to  health,  all  members  of  society, </text>
<text top="177" left="123" width="367" height="11" font="3">including  health  professionals  and  the  private  business  sector  have  responsibilities </text>
<text top="189" left="123" width="221" height="11" font="3">regarding  the  realization  of  the  right  to  health.</text>
<text top="189" left="345" width="6" height="6" font="18">57</text>
<text top="189" left="352" width="139" height="11" font="3">  As  indicated  in  the  Guiding </text>
<text top="201" left="123" width="367" height="11" font="3">Principles  on  Business  and  Human  Rights:  Implementing  the  United  Nations </text>
<text top="213" left="123" width="367" height="11" font="3">“Protect, Respect and Remedy” Framework, private actors have the responsibility to </text>
<text top="225" left="123" width="101" height="11" font="3">“respect” human rights.</text>
<text top="225" left="226" width="6" height="6" font="18">58</text>
<text top="225" left="232" width="5" height="11" font="3">  </text>
<text top="243" left="123" width="367" height="11" font="3">56.  Private  hospital  and  insurance  boards  and  other  institutions  responsible  for  the </text>
<text top="255" left="123" width="367" height="11" font="3">financing and provision of health care or underlying determinants have an important </text>
<text top="267" left="123" width="367" height="11" font="3">role  to  play  in  combating  corruption  and  lack  of  transparency  within  their </text>
<text top="279" left="123" width="367" height="11" font="3">organizations. They must ensure that they comply with national laws and regulations </text>
<text top="291" left="123" width="368" height="11" font="3">regarding  corruption  and  human  rights.  They  may  adopt  an  anti-corruption  strategy, </text>
<text top="303" left="123" width="367" height="11" font="3">including  internal  regulations  aimed  at  prohibiting  and  preventing  the  diversion  of </text>
<text top="315" left="123" width="367" height="11" font="3">budgets,  medicines  or  medical  supplies  for  personal  advantage;  the  acceptance  of </text>
<text top="327" left="123" width="365" height="11" font="3">informal  payments  by  their  health  personnel;  preferential  treatment  for  well -</text>
<text top="339" left="123" width="367" height="11" font="3">connected  individuals;  the  use  of  hospital  equipment  for  private  business;  the </text>
<text top="351" left="123" width="367" height="11" font="3">improper  referral  of  public  hospital  patients  to  private  practices;  and  illegitimate </text>
<text top="363" left="123" width="367" height="11" font="3">absenteeism  of  medical  personnel  while  being  paid.  When  it  comes  to  preventing </text>
<text top="375" left="123" width="367" height="11" font="3">informal payments, the creation of individual contracts with personnel and increased </text>
<text top="387" left="123" width="292" height="11" font="3">pay  scales  while  sanctioning  poor  performance  are  recommended.</text>
<text top="387" left="415" width="6" height="6" font="18">59</text>
<text top="387" left="422" width="69" height="11" font="3">  In  the  case  of </text>
<text top="399" left="123" width="367" height="11" font="3">whistle-blowers, hospital boards and other actors should refrain from punitive actions </text>
<text top="411" left="123" width="367" height="11" font="3">and  provide  adequate  protection  and  guarantees  to  safeguard  their  personnel  and </text>
<text top="423" left="123" width="39" height="11" font="3">services. </text>
<text top="441" left="123" width="368" height="11" font="3">57.  Organizations  administering  health  insurance  schemes  and  insurance </text>
<text top="453" left="123" width="367" height="11" font="3">regulators  have  a  responsibility  to  prevent  embezzlement,  theft  and  illicit </text>
<text top="465" left="123" width="367" height="11" font="3">enrichment  from  the  health  insurance  budget  and  bias  in  favour  of  certain </text>
<text top="477" left="123" width="367" height="11" font="3">procedures,  medical  professionals  or  products  due  to  conflicts  of  interests.  They </text>
<text top="489" left="123" width="368" height="11" font="3">should  avoid  adverse  selection  practices  leading  to  patients  being  refused  on  the </text>
<text top="501" left="123" width="286" height="11" font="3">basis of their health status, age, financial capacity or other factors.</text>
<text top="501" left="410" width="6" height="6" font="18">60</text>
<text top="501" left="417" width="5" height="11" font="3">  </text>
<text top="519" left="123" width="367" height="11" font="3">58.  The  medical  profession  has  a  responsibility  to  abstain  from  unethical  and </text>
<text top="531" left="123" width="367" height="11" font="3">unprofessional  behaviour  under  its  professional  codes,  which  often  emphasize  a </text>
<text top="543" left="123" width="224" height="11" font="3">commitment to integrity and non-corrupt behaviour.</text>
<text top="543" left="348" width="6" height="6" font="18">61</text>
<text top="543" left="354" width="136" height="11" font="3"> Among other acts, the medical </text>
<text top="555" left="123" width="367" height="11" font="3">profession  is  to  refrain  from  favouritism  and  other  forms  of  preferential  treatment </text>
<text top="567" left="123" width="367" height="11" font="3">for  well-connected  individuals;  accepting  bribes;  using  hospital  equipment  for </text>
<text top="579" left="123" width="367" height="11" font="3">private  business;  and  referring  public  hospital  patients  to  their  private  practices. </text>
<text top="591" left="123" width="367" height="11" font="3">They  should  remain  independent  from  outside  organizations  that  have  vested </text>
<text top="618" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="632" left="95" width="2" height="8" font="0"> </text>
<text top="630" left="114" width="6" height="5" font="18">56</text>
<text top="632" left="120" width="293" height="8" font="0">  Independent Accountability Panel, “2016: old challenges, new hope s”, p. 11. </text>
<text top="643" left="95" width="2" height="8" font="0"> </text>
<text top="641" left="114" width="6" height="5" font="18">57</text>
<text top="643" left="120" width="353" height="8" font="0">  See Committee on Economic, Social and Cultural Rights, general comment No. 14, para. 42.  </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">58</text>
<text top="653" left="120" width="19" height="8" font="0">  See </text>
<text top="651" left="139" width="321" height="9" font="20"><i>Guiding Principles on Business and Human Rights: Implementing the United Nations </i></text>
<text top="662" left="123" width="164" height="9" font="20"><i>“Protect, Respect and Remedy” Framework</i></text>
<text top="662" left="288" width="136" height="9" font="0"> (United Nations publication, Sales  </text>
<text top="672" left="123" width="114" height="9" font="0">No. HR/PUB/11/04, chap. II). </text>
<text top="685" left="95" width="2" height="8" font="0"> </text>
<text top="683" left="114" width="6" height="5" font="18">59</text>
<text top="685" left="120" width="316" height="8" font="0">  Taryn Vian, “Corruption in hospital administration”, in Transparency International, </text>
<text top="683" left="437" width="28" height="9" font="20"><i>Global </i></text>
<text top="693" left="123" width="90" height="9" font="20"><i>Corruption Report 2006</i></text>
<text top="693" left="214" width="45" height="9" font="0">, pp. 49-55. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">60</text>
<text top="706" left="120" width="360" height="8" font="0">  Maureen Lewis, “Governance and corruption in public health care systems”, Center for Global </text>
<text top="714" left="123" width="196" height="9" font="0">Development, working paper No. 78, January 2006. </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">61</text>
<text top="727" left="120" width="354" height="8" font="0">  See World Medical Association, International Code of Medical Ethics, last amended in 2006.  </text>
</page>
<page number="16" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>16/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="368" height="11" font="3">interests  in  their  clinical  activities.  They  should  avoid  conflicts  of  interest  that </text>
<text top="85" left="123" width="255" height="11" font="3">compromise their decisions regarding the care of patients.  </text>
<text top="103" left="123" width="367" height="11" font="3">59.  Education  in  the  health-care  sector  is  one  important  element  in  that  regard. </text>
<text top="115" left="123" width="367" height="11" font="3">The  doctrine  of  the  “five-star  doctor”  needs  to  be  reaffirmed  to  translate  modern </text>
<text top="127" left="123" width="367" height="11" font="3">values  and  scientific  evidence  into  everyday  medical  practice.  Modern  medical </text>
<text top="139" left="123" width="367" height="11" font="3">doctors  need  to  be  not  only  good  clinicians  but  also  effective  community  leaders, </text>
<text top="151" left="123" width="367" height="11" font="3">communicators,  decision  makers  and  managers.  That  philosophy  should  be </text>
<text top="163" left="123" width="367" height="11" font="3">complemented by  a strong  human rights-based approach  and  evidence  gained  from </text>
<text top="175" left="123" width="155" height="11" font="3">the modern public health approach. </text>
<text top="193" left="123" width="367" height="11" font="3">60.  While  medical  doctors  and  other  health-care  workers  are  accountable  and </text>
<text top="205" left="123" width="367" height="11" font="3">responsible for ethical conduct and non-corrupt behaviour, it is crucial that corrupt </text>
<text top="217" left="123" width="367" height="11" font="3">practices  and  institutional  corruption  do  not  affect  decisions  made  at  the  level  of </text>
<text top="229" left="123" width="367" height="11" font="3">academic medicine. Medical schools that train future medical doctors and carry out </text>
<text top="241" left="123" width="368" height="11" font="3">medical research and university hospitals that provide a tertiary level of health -care </text>
<text top="253" left="123" width="367" height="11" font="3">services  and  use  expensive  biomedical  technologies  have  a  key  role  in  preventing </text>
<text top="265" left="123" width="367" height="11" font="3">corruption  in  the  rest  of  the  health-care  system.  It  is  very  important  to  use  the </text>
<text top="277" left="123" width="367" height="11" font="3">principle  of  academic  autonomy  in  a  responsible  way.  The  academic  medical  elite </text>
<text top="289" left="123" width="367" height="11" font="3">has  enormous  power  over  decision-making  and  when  they  advise  policymakers  on </text>
<text top="301" left="123" width="341" height="11" font="3">how to invest resources proper accountability mechanisms need to be in place.  </text>
<text top="319" left="123" width="367" height="11" font="3">61.  Within  the  health  sector,  the  pharmaceutical  industry  stands  out  as  being </text>
<text top="331" left="123" width="368" height="11" font="3">particularly  prone  to  corruption.  Corrupt  practices  take  place  at  all  stages  of  the </text>
<text top="343" left="123" width="367" height="11" font="3">pharmaceutical  value  chain,  including  during  research  and  development, </text>
<text top="355" left="123" width="367" height="11" font="3">manufacturing,  registration,  distribution,  procurement  and  marketing.  The  key </text>
<text top="367" left="123" width="368" height="11" font="3">problems  are  a  lack  of  objective  data  and  understanding  of  corruption  in  the  </text>
<text top="379" left="123" width="367" height="11" font="3">pharmaceutical sector, a weak legislative and regulatory framework, potential undue </text>
<text top="391" left="123" width="368" height="11" font="3">influence  from  companies  and  a  lack  of  leadership  committed  to  anti -corruption </text>
<text top="403" left="123" width="30" height="11" font="3">efforts.</text>
<text top="403" left="154" width="6" height="6" font="18">62</text>
<text top="403" left="161" width="5" height="11" font="3">  </text>
<text top="421" left="123" width="367" height="11" font="3">62.  While  governments  have  the  primary  duty  to  regulate  and  oversee  the </text>
<text top="433" left="123" width="367" height="11" font="3">pharmaceutical  sector,  the  pharmaceutical  industry  has  a  responsibility  to  engage </text>
<text top="445" left="123" width="367" height="11" font="3">with governments on the issue of corruption. It has an independent responsibility to </text>
<text top="457" left="123" width="368" height="11" font="3">prevent corruption throughout its value chain, inter alia, through institutional checks </text>
<text top="469" left="123" width="367" height="11" font="3">and  balances,  protection  and  security  of  medicines  and  the  adoption  of  monitoring </text>
<text top="481" left="123" width="368" height="11" font="3">and  accountability  procedures  such  as  audits  and  whistle-blowing  mechanisms  for </text>
<text top="493" left="123" width="103" height="11" font="3">all staff in the company.</text>
<text top="493" left="227" width="6" height="6" font="18">63</text>
<text top="493" left="234" width="5" height="11" font="3">  </text>
<text top="512" left="123" width="1" height="5" font="8"> </text>
<text top="518" left="123" width="1" height="5" font="8"> </text>
<text top="525" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="522" left="94" width="373" height="16" font="9"><b>IV.  Issue in focus: corruption and the right to mental health </b></text>
<text top="539" left="123" width="1" height="5" font="8"> </text>
<text top="545" left="123" width="1" height="5" font="8"> </text>
<text top="550" left="123" width="367" height="11" font="3">63.  The  Special  Rapporteur  has raised  the issue  of the  global burden  of obstacles </text>
<text top="562" left="123" width="20" height="11" font="3">(see<a href="https://undocs.org/A/HRC/35/21"> </a></text>
<text top="562" left="143" width="59" height="11" font="21"><a href="https://undocs.org/A/HRC/35/21">A/HRC/35/21</a></text>
<text top="562" left="203" width="288" height="11" font="3"><a href="https://undocs.org/A/HRC/35/21">)</a> that persists in mental health-care systems globally and how this </text>
<text top="574" left="123" width="367" height="11" font="3">hinders  the  realization  of  the  right  to  health.  Obstacles  include  the  overuse  of </text>
<text top="586" left="123" width="367" height="11" font="3">biomedical  model  and  biomedical  interventions,  in  particular  psychotropic </text>
<text top="598" left="123" width="367" height="11" font="3">medications;  power  asymmetries;  and  the  use  of  biased  evidence.  The  Special </text>
<text top="610" left="123" width="310" height="11" font="3">Rapporteur advocated for a shift in mental health policies and servi ces. </text>
<text top="628" left="123" width="367" height="11" font="3">64.  Existing evidence shows that mental health policies and services are especially </text>
<text top="640" left="123" width="367" height="11" font="3">prone  to  ineffective  and  corrupt  practices,  as  well  as  the  use  of  biased  evidence. </text>
<text top="652" left="123" width="368" height="11" font="3">These obstacles, if not properly addressed, divert mental health policies and servic es </text>
<text top="664" left="123" width="367" height="11" font="3">from  the  effective  realization  of  the  right  to  health  and  hinder  implementation  of </text>
<text top="676" left="123" width="367" height="11" font="3">Sustainable  Development  Goals,  including  Goal  3  and  a  very  important  target:  to </text>
<text top="688" left="123" width="172" height="11" font="3">promote mental health and well-being.  </text>
<text top="702" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">62</text>
<text top="716" left="120" width="124" height="8" font="0">  Transparency International UK, </text>
<text top="714" left="245" width="153" height="9" font="20"><i>Corruption in the Pharmaceutical Sector</i></text>
<text top="714" left="398" width="75" height="9" font="0"> (June 2016), p. 28. </text>
<text top="727" left="95" width="2" height="8" font="0"> </text>
<text top="725" left="114" width="6" height="5" font="18">63</text>
<text top="727" left="120" width="49" height="8" font="0">  Ibid., p. 27. </text>
</page>
<page number="17" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="22" size="10" family="Times New Roman,Italic" color="#000000"/>
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>17/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="368" height="11" font="3">65.  Mental  health  policies  and  services  illustrate  how  lack  of  transparency  and </text>
<text top="85" left="123" width="367" height="11" font="3">accountability  in  the  relationships  between  the  pharmaceutical  industry  and </text>
<text top="97" left="123" width="367" height="11" font="3">academic medicine can lead to institutional corruption and have a detrimental effect </text>
<text top="109" left="123" width="368" height="11" font="3">on  mental health policies and services, not only on a national or  regional scale but </text>
<text top="121" left="123" width="105" height="11" font="3">also at the global level.  </text>
<text top="139" left="123" width="367" height="11" font="3">66.  As  mentioned  above,  institutional  corruption  occurs  when  an  organization  or </text>
<text top="151" left="123" width="367" height="11" font="3">institution is no longer sufficiently independent to pursue its stated goals or mission </text>
<text top="163" left="123" width="367" height="11" font="3">effectively.  It  occurs  when  systematic  practices  develop  within  an  institution  that </text>
<text top="175" left="123" width="367" height="11" font="3">are  legal,  accepted  and  normative,  but  nonetheless  undermine  its  integrity.  Thus, </text>
<text top="187" left="123" width="367" height="11" font="3">institutional  corruption  results  from  the  normalization  of  behaviours  that </text>
<text top="199" left="123" width="368" height="11" font="3">compromise truth seeking and from perverse incentive structures (e.g., promotions; </text>
<text top="211" left="123" width="368" height="11" font="3">peer-reviewed publications) that reward problematic behaviour. It is a solution -, not </text>
<text top="223" left="123" width="348" height="11" font="3">blame-, oriented framework — a “bad barrel” rather than a “bad apple” problem.</text>
<text top="223" left="472" width="6" height="6" font="18">64</text>
<text top="223" left="479" width="5" height="11" font="3">  </text>
<text top="241" left="123" width="368" height="11" font="3">67.  Representatives  of  academic  psychiatry  and  other  mental  health  researchers </text>
<text top="253" left="123" width="367" height="11" font="3">can have significant and long-lasting ties to drug manufacturers yet believe that they </text>
<text top="265" left="123" width="367" height="11" font="3">are  immune  to  explicit  or  implicit  bias,  provided  that  they  disclose  these  ties. </text>
<text top="277" left="123" width="368" height="11" font="3">Similarly,  journal  editors  can  have  financial  ties  to  the  same  drug  comp anies  and </text>
<text top="289" left="123" width="367" height="11" font="3">publish  these  studies,  also  believing  that  their  judgment  is  not  compromised. </text>
<text top="301" left="123" width="367" height="11" font="3">However, there are decades of research demonstrating that scientists are not immune </text>
<text top="313" left="123" width="368" height="11" font="3">to  guild  interests  and  implicit  bias  and  that  transparency  or  disclosure  of  financia l </text>
<text top="325" left="123" width="204" height="11" font="3">conflicts of interest is an insufficient solution.  </text>
<text top="343" left="123" width="367" height="11" font="3">68.  Thus, the framework of institutional corruption highlights both the harm done </text>
<text top="355" left="123" width="367" height="11" font="3">and what is lost, namely, harm to patients; loss of public trust and confidence in the </text>
<text top="367" left="123" width="367" height="11" font="3">integrity  of  academic  medicine;  and  distortion  of  the  scientific  evidence  base.  It </text>
<text top="379" left="123" width="367" height="11" font="3">exposes the economies of influence that contribute to those harms and losses and it </text>
<text top="391" left="123" width="367" height="11" font="3">is  a  call  for  action  to  neutralize  those  influences.  Below,  the  Special  Rapporteur </text>
<text top="403" left="123" width="367" height="11" font="3">reviews  three  main  areas  in  the  mental  health  field  using  this  framework,  namely, </text>
<text top="415" left="123" width="367" height="11" font="3">the  process  of  development  and  promotion  of  diagnostic  categories  for  mental </text>
<text top="427" left="123" width="341" height="11" font="3">health conditions, psychotropic drug research and clinical practice guidelines.   </text>
<text top="445" left="123" width="166" height="11" font="3">69.  Because  of  its  global  reach,  the </text>
<text top="445" left="291" width="200" height="11" font="22"><i>Diagnostic  and  Statistical  Manual  of  Mental </i></text>
<text top="457" left="123" width="42" height="11" font="22"><i>Disorders</i></text>
<text top="457" left="166" width="325" height="11" font="3"> (DSM) has been referred to as the “bible” of psychiatric diagnosis and is </text>
<text top="469" left="123" width="367" height="11" font="3">used  worldwide  in  psychiatric  research.  However,  over  the  last  decade  there  have </text>
<text top="481" left="123" width="368" height="11" font="3">been  increasing  concerns  that  the  interconnected  needs  of  the  pharmaceutical </text>
<text top="493" left="123" width="367" height="11" font="3">industry and the psychiatric community may have played a role in the development </text>
<text top="505" left="123" width="226" height="11" font="3">or expansion of questionable diagnostic categories.  </text>
<text top="523" left="123" width="368" height="11" font="3">70.  A  2006  study  found  that  the  majority  of  DSM-IV  (fourth  edition  of  the </text>
<text top="535" left="123" width="367" height="11" font="3">Manual)  panel  members had financial  ties to drug companies and that 100 per cent </text>
<text top="547" left="123" width="367" height="11" font="3">of the  Mood  Disorders  work  group  and  the  Schizophrenia  and Psychotic  Disorders </text>
<text top="559" left="123" width="367" height="11" font="3">work group had commercial ties to the companies that manufacture antidepressants </text>
<text top="571" left="123" width="368" height="11" font="3">and  antipsychotics.  Despite  a  disclosure  policy  imp lemented  by  the  American </text>
<text top="583" left="123" width="367" height="11" font="3">Psychiatric  Association  one  year  later,  the  majority  of  individuals  serving  on  the </text>
<text top="595" left="123" width="368" height="11" font="3">DSM-5 (fifth edition of the Manual) still had such ties and, as with the DSM-IV, the </text>
<text top="607" left="123" width="368" height="11" font="3">most  conflicted  panels  were  those  for  which  pharmacological  treatment  was  the </text>
<text top="619" left="123" width="95" height="11" font="3">first-line intervention.</text>
<text top="619" left="219" width="6" height="6" font="18">65</text>
<text top="619" left="225" width="5" height="11" font="3">  </text>
<text top="637" left="123" width="367" height="11" font="3">71.  The widening of disease boundaries has medicalized normal human experience </text>
<text top="649" left="123" width="367" height="11" font="3">(e.g.,  “social  anxiety  disorder”),  resulting  in  expanded  markets  for  treatment  and </text>
<text top="681" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="695" left="95" width="2" height="8" font="0"> </text>
<text top="693" left="114" width="6" height="5" font="18">64</text>
<text top="695" left="120" width="71" height="8" font="0">  Lawrence Lessig, </text>
<text top="693" left="192" width="268" height="9" font="20"><i>Republic, Lost: How Money Corrupts Congress — and a Plan to Stop It</i></text>
<text top="693" left="460" width="25" height="9" font="0"> (New </text>
<text top="704" left="123" width="125" height="9" font="0">York and Boston, Twelve, 2011). </text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">65</text>
<text top="716" left="120" width="340" height="8" font="0">  Joel Lexchin and others, “Pharmaceutical industry sponsorship and research outcome and </text>
<text top="725" left="123" width="116" height="9" font="0">quality: systematic review”, in </text>
<text top="725" left="241" width="89" height="9" font="20"><i>British Medical Journal</i></text>
<text top="725" left="330" width="145" height="9" font="0">, vol. 326 (May 2003), pp. 1167-1170. </text>
</page>
<page number="18" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>18/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="368" height="11" font="3">diverting  attention  away  from  the  cultural,  socioeconomic  and  political  context  of </text>
<text top="85" left="123" width="86" height="11" font="3">emotional distress.  </text>
<text top="103" left="123" width="367" height="11" font="3">72.  Studies  have  revealed  that  commercially  funded  trials  are  up  to  four  times </text>
<text top="115" left="123" width="367" height="11" font="3">more  likely  to  report  industry-friendly  results  than  trials  without  such  financial </text>
<text top="127" left="123" width="90" height="11" font="3">conflicts  of  interest.</text>
<text top="127" left="214" width="6" height="6" font="18">66</text>
<text top="127" left="221" width="270" height="11" font="3">  In  addition,  there  is  clear  evidence  of  publication  bias  in </text>
<text top="139" left="123" width="367" height="11" font="3">psychotropic drug trials; research demonstrating the ineffectiveness of a drug can be </text>
<text top="151" left="123" width="279" height="11" font="3">suppressed  or  written  in  a  way  that  conveys  a  positive  result.</text>
<text top="151" left="403" width="6" height="6" font="18">67</text>
<text top="151" left="410" width="81" height="11" font="3">  Such  publication </text>
<text top="163" left="123" width="367" height="11" font="3">biases  result  in  an  inflated  perception  of  efficacy  and  an  underestimation  of  the </text>
<text top="175" left="123" width="159" height="11" font="3">harms of psychotropic medications.  </text>
<text top="193" left="123" width="367" height="11" font="3">73.  The Special Rapporteur observes that pharmaceutical companies have a vested </text>
<text top="205" left="123" width="367" height="11" font="3">interest in finding a new indication (namely, a new disorder) for their drugs when a </text>
<text top="217" left="123" width="367" height="11" font="3">patent expires since  this allows the drug  manufacturer to obtain an additional three </text>
<text top="229" left="123" width="367" height="11" font="3">years  of  exclusivity  for  the  drug  in  question.  Pharmaceutical  companies  have  used </text>
<text top="241" left="123" width="367" height="11" font="3">“exclusivity”  as  an  informal  mechanism  to  effectively  extend  patent  protection  for </text>
<text top="253" left="123" width="76" height="11" font="3">that time period.  </text>
<text top="271" left="123" width="367" height="11" font="3">74.  The  inclusion  of  new  disorders in  DSM-5 referred to  above  have  led  some  to </text>
<text top="283" left="123" width="365" height="11" font="3">question whether the updated edition inadvertently functioned as a vehicle for high -</text>
<text top="295" left="123" width="367" height="11" font="3">profit  patent  extensions.  It  was  found  that  in  the  majority  of  clinical  trials  testing </text>
<text top="307" left="123" width="367" height="11" font="3">drugs  for  new  DSM  disorders  (e.g.,  “Binge-eating  disorder”),  there  were </text>
<text top="319" left="123" width="367" height="11" font="3">commercial ties between DSM-5 panel members and the pharmaceutical companies </text>
<text top="331" left="123" width="325" height="11" font="3">that manufactured the drugs that were being tested for these new disorders.</text>
<text top="331" left="450" width="6" height="6" font="18">68</text>
<text top="331" left="456" width="35" height="11" font="3"> This is </text>
<text top="343" left="123" width="368" height="11" font="3">not  to  suggest  any  wrongdoing  on  the  part  of  DSM  panel  members,  but  rather  to </text>
<text top="355" left="123" width="367" height="11" font="3">emphasize  the  economies  of  influence  at  play  and  that  transparency  alone  is  an </text>
<text top="367" left="123" width="194" height="11" font="3">insufficient measure for systemic problems.  </text>
<text top="385" left="123" width="367" height="11" font="3">75.  The  Special  Rapporteur  is  seriously  concerned  that  treatment  guidelines  for </text>
<text top="397" left="123" width="367" height="11" font="3">mental health conditions are particularly vulnerable to industry capture because the </text>
<text top="409" left="123" width="367" height="11" font="3">absence  of  biological  markers  for  mental  health  conditions  increases  clinical </text>
<text top="421" left="123" width="367" height="11" font="3">uncertainty  and  subjective  judgments.  Bias  in  such  guidelines  creates  the  potential </text>
<text top="433" left="123" width="367" height="11" font="3">to expose patients to harm from unnecessary treatment or from treatment that is not </text>
<text top="445" left="123" width="218" height="11" font="3">evidence-based and leads to a drain on resources.  </text>
<text top="463" left="123" width="368" height="11" font="3">76.  When  guidelines  are  produced  by  medical  specialty  groups,  especially  those </text>
<text top="475" left="123" width="365" height="11" font="3">with  strong  and  pervasive  industry  ties,  these  groups  tend  to  recommend  market -</text>
<text top="487" left="123" width="367" height="11" font="3">driven  treatment  options  (e.g.  pharmacotherapy)  when  less  expensive  and  safer </text>
<text top="499" left="123" width="337" height="11" font="3">(e.g.,  lifestyle  change  or  psychosocial  support)  approaches  are  available.</text>
<text top="499" left="461" width="6" height="6" font="18">69</text>
<text top="499" left="468" width="23" height="11" font="3">  For </text>
<text top="511" left="123" width="106" height="11" font="3">example,  meta-analyses,</text>
<text top="511" left="230" width="15" height="6" font="18">70,71</text>
<text top="511" left="245" width="209" height="11" font="3">  re-analyses  of  antidepressant  clinical  trial  data</text>
<text top="511" left="454" width="15" height="6" font="18">72,73</text>
<text top="511" left="469" width="22" height="11" font="3">  and </text>
<text top="534" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="548" left="95" width="2" height="8" font="0"> </text>
<text top="546" left="114" width="6" height="5" font="18">66</text>
<text top="548" left="120" width="23" height="8" font="0">  Ibid. </text>
<text top="558" left="95" width="2" height="8" font="0"> </text>
<text top="557" left="114" width="6" height="5" font="18">67</text>
<text top="558" left="120" width="345" height="8" font="0">  Erick Turner and others, “Selective publication of antidepressant trials and its influence on </text>
<text top="567" left="123" width="73" height="9" font="0">apparent efficacy”, </text>
<text top="567" left="197" width="128" height="9" font="20"><i>New England Journal of Medicine</i></text>
<text top="567" left="325" width="143" height="9" font="0">, vol. 358, No. 3 (2008), pp. 252-260. </text>
<text top="579" left="95" width="2" height="8" font="0"> </text>
<text top="578" left="114" width="6" height="5" font="18">68</text>
<text top="579" left="120" width="363" height="8" font="0">  L. Cosgrove and others, “Tripartite conflicts of interest and high stakes patent extensions in the </text>
<text top="588" left="123" width="36" height="9" font="0">DSM-5”, </text>
<text top="588" left="160" width="133" height="9" font="20"><i>Psychotherapy and Psychosomatics</i></text>
<text top="588" left="293" width="113" height="9" font="0">, vol. 83 (2014), pp. 106-113. </text>
<text top="601" left="95" width="2" height="8" font="0"> </text>
<text top="599" left="114" width="6" height="5" font="18">69</text>
<text top="601" left="120" width="365" height="8" font="0">  Lisa Cosgrove and others, “From caveat emptor to caveat venditor: time to stop the  influence of </text>
<text top="609" left="123" width="165" height="9" font="0">money on practice guideline development”, </text>
<text top="609" left="289" width="158" height="9" font="20"><i>Journal of Evaluation in Clinical Practice</i></text>
<text top="609" left="447" width="33" height="9" font="0">, vol. 20 </text>
<text top="620" left="123" width="79" height="9" font="0">(2015), pp. 809-812. </text>
<text top="632" left="95" width="2" height="8" font="0"> </text>
<text top="630" left="114" width="6" height="5" font="18">70</text>
<text top="632" left="120" width="356" height="8" font="0">  Irving Kirsch and others, “Initial severity and antidepressant benefits: a meta -analysis of data </text>
<text top="641" left="123" width="186" height="9" font="0">submitted to the Food and Drug Administration”, </text>
<text top="641" left="310" width="58" height="9" font="20"><i>PLOS Medicine</i></text>
<text top="641" left="369" width="84" height="9" font="0">, vol. 5, No. 2 (2008). </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">71</text>
<text top="653" left="120" width="355" height="8" font="0">  Jay Fournier and others, “Antidepressant drug effects and depression severity: a patient -level </text>
<text top="662" left="123" width="60" height="9" font="0">meta-analysis”, </text>
<text top="662" left="184" width="169" height="9" font="20"><i>Journal of the American Medical Association</i></text>
<text top="662" left="353" width="134" height="9" font="0">, vol. 303, No. 1 (2010), pp. 47-53. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">72</text>
<text top="674" left="120" width="360" height="8" font="0">  Toshi A. Furukawa and others, “Comparative efficacy and acceptability of first -generation and </text>
<text top="683" left="123" width="346" height="9" font="0">second-generation antidepressants in the acute treatment of major depression: protocol for a </text>
<text top="693" left="123" width="102" height="9" font="0">network meta-analysis”, in </text>
<text top="693" left="226" width="39" height="9" font="20"><i>BMJ Open</i></text>
<text top="693" left="266" width="84" height="9" font="0">, vol. 6, No. 7 (2016). </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">73</text>
<text top="706" left="120" width="352" height="8" font="0">  Joanna Le Noury, “Restoring study 329: efficacy and harms of paroxetine and imipramine in </text>
<text top="714" left="123" width="187" height="9" font="0">treatment of major depression in adolescence”, in </text>
<text top="714" left="311" width="89" height="9" font="20"><i>British Medical Journal</i></text>
<text top="714" left="401" width="70" height="9" font="0">, vol. 351 (2015),  </text>
<text top="725" left="123" width="31" height="9" font="0">p. 802). </text>
</page>
<page number="19" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>19/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="74" height="11" font="3">narrative reviews</text>
<text top="73" left="198" width="6" height="6" font="18">74</text>
<text top="73" left="205" width="286" height="11" font="3"> have explicitly concluded that because of the risk benefit profile, </text>
<text top="85" left="123" width="367" height="11" font="3">antidepressants should not be used as a first-line intervention for mild depression, as </text>
<text top="97" left="123" width="367" height="11" font="3">this  may  result  in  overtreatment.  Nonetheless,  some  guidelines  produced  by </text>
<text top="109" left="123" width="367" height="11" font="3">industry-funded  psychiatry  specialty  organizations  continue  to  use  a predominately </text>
<text top="121" left="123" width="368" height="11" font="3">biological  framework  and  recommend  antidepressant  medication  as  a  first -line </text>
<text top="133" left="123" width="164" height="11" font="3">intervention for even mild depression.</text>
<text top="133" left="288" width="6" height="6" font="18">75</text>
<text top="133" left="294" width="5" height="11" font="3">  </text>
<text top="151" left="123" width="368" height="11" font="3">77.  Institutional corruption in the mental health system has several consequenc es. </text>
<text top="163" left="123" width="367" height="11" font="3">One of them is the medicalization of human diversity and misery, which expands the </text>
<text top="175" left="123" width="367" height="11" font="3">number  of  patients  labelled  with  mental  illness.  According  to  WHO,  more  than </text>
<text top="187" left="123" width="367" height="11" font="3">300 million people of all ages globally suffer from depression, and depression is the </text>
<text top="199" left="123" width="173" height="11" font="3">leading  cause  of  disability  worldwide.</text>
<text top="199" left="298" width="6" height="6" font="18">76</text>
<text top="199" left="304" width="187" height="11" font="3">  However,  some  researchers  have  raised </text>
<text top="211" left="123" width="367" height="11" font="3">serious questions about the reliability of these disease burden estimates. One study </text>
<text top="223" left="123" width="367" height="11" font="3">concluded  that  poor-quality  data  limit  the  interpretation  and  validity  of  global </text>
<text top="235" left="123" width="367" height="11" font="3">burden  of  depression  estimates.  They  warn  that  uncritical  application  of  these </text>
<text top="247" left="123" width="367" height="11" font="3">estimates  to  international  health-care  policymaking  could  divert  scarce  resources </text>
<text top="259" left="123" width="178" height="11" font="3">from  other  public  health-care  priorities.</text>
<text top="259" left="302" width="6" height="6" font="18">77</text>
<text top="259" left="308" width="183" height="11" font="3">  While  industry  certainly  profits  from  a </text>
<text top="271" left="123" width="367" height="11" font="3">biological  approach that  emphasizes  these disease  burden  estimates, the  attainment </text>
<text top="283" left="123" width="251" height="11" font="3">of the right to health globally becomes ever more elusive. </text>
<text top="301" left="123" width="367" height="11" font="3">78.  It  is  the  global  burden  of  such  obstacles,  rather  than  the  global  burden  of </text>
<text top="313" left="123" width="368" height="11" font="3">mental disorders, that should be addressed as a priority in mental health policies and </text>
<text top="325" left="123" width="367" height="11" font="3">services.  In  that  connection,  corruption  in  mental  health  research,  education  and </text>
<text top="337" left="123" width="351" height="11" font="3">services should be addressed as one of the most important concerns or obstacles.  </text>
<text top="355" left="123" width="368" height="11" font="3">79.  Indeed,  institutional  corruption  in  mental  health  has  reinforced  t he </text>
<text top="367" left="123" width="367" height="11" font="3">medicalization  of  emotional  distress  and  has  thereby  undermined  the  ability  of </text>
<text top="379" left="123" width="367" height="11" font="3">decision  makers  to  focus  on  the  underlying  and  social  determinants  of  health  and </text>
<text top="391" left="123" width="367" height="11" font="3">address the way in which the health of socially disadvantaged groups is determined </text>
<text top="403" left="123" width="273" height="11" font="3">by exposures to societal and environmental risks and resources.</text>
<text top="403" left="398" width="6" height="6" font="18">78</text>
<text top="403" left="404" width="5" height="11" font="3">  </text>
<text top="421" left="123" width="367" height="11" font="3">80.  Certainly, many people are in need of mental health services and often they do </text>
<text top="433" left="123" width="367" height="11" font="3">not have access to them. However, all stakeholders, especially policymakers and the </text>
<text top="445" left="123" width="367" height="11" font="3">leadership of the psychiatric profession, must address the fact that overdiagnosis and </text>
<text top="457" left="123" width="368" height="11" font="3">overtreatment  of  milder  forms  of  anxiety,  depression,  inattention,  age -related </text>
<text top="469" left="123" width="367" height="11" font="3">cognitive  decline  and  the  like  unnecessarily  creates  pathological  identities  in  people </text>
<text top="481" left="123" width="367" height="11" font="3">and  exposes  individuals  to  the  iatrogenic  effects  of  labelling  and  the  side  effects  of </text>
<text top="493" left="123" width="367" height="11" font="3">treatments  without  offering  them  benefit  to  offset  the  harm.  Individualizing, </text>
<text top="505" left="123" width="367" height="11" font="3">decontextualizing and medicalizing emotional distress reinforces health disparities by </text>
<text top="517" left="123" width="367" height="11" font="3">reducing the capacity of health systems to serve those with more severe mental health </text>
<text top="529" left="123" width="364" height="11" font="3">problems — the ones, often from disadvantaged groups, who need the care the most.  </text>
<text top="547" left="123" width="367" height="11" font="3">81.  The  medicalization  of  the  public  mental  health  field  is  driven  by  a  lack  of </text>
<text top="559" left="123" width="367" height="11" font="3">transparency  and  accountability  in  medical  education  and  research  and  leads  to </text>
<text top="576" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="590" left="95" width="2" height="8" font="0"> </text>
<text top="588" left="114" width="6" height="5" font="18">74</text>
<text top="590" left="120" width="369" height="8" font="0">  Baumeister H., “Inappropriate prescriptions of antidepressant  drugs in patients with subthreshold </text>
<text top="599" left="123" width="242" height="9" font="0">to mild depression: time for the evidence to become practice” in </text>
<text top="599" left="366" width="110" height="9" font="20"><i>Journal of affective disorders</i></text>
<text top="599" left="477" width="5" height="9" font="0">, </text>
<text top="609" left="123" width="138" height="9" font="0">vol. 139, No. 3 (2012), pp. 240-243. </text>
<text top="622" left="95" width="2" height="8" font="0"> </text>
<text top="620" left="114" width="6" height="5" font="18">75</text>
<text top="622" left="120" width="364" height="8" font="0">  L. Cosgrove and others, “Conflicts of Interest and the Presence of Methodologists  on Guideline </text>
<text top="630" left="123" width="331" height="9" font="0">Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major </text>
<text top="641" left="123" width="85" height="9" font="0">Depressive Disorder”, </text>
<text top="641" left="209" width="133" height="9" font="20"><i>Psychotherapy and Psychosomatics</i></text>
<text top="641" left="342" width="138" height="9" font="0">, vol. 86, No. 3 (2017), pp. 168-170. </text>
<text top="653" left="95" width="2" height="8" font="0"> </text>
<text top="651" left="114" width="6" height="5" font="18">76</text>
<text top="653" left="120" width="349" height="8" font="0">  WHO, “Depression”, fact sheet, 2017, available from www.who.in t/mediacentre/factsheets/ </text>
<text top="662" left="123" width="39" height="9" font="0">fs369/en/. </text>
<text top="674" left="95" width="2" height="8" font="0"> </text>
<text top="672" left="114" width="6" height="5" font="18">77</text>
<text top="674" left="120" width="370" height="8" font="0">  Petra Brhlikova, Allyson M. Pollock and Rachel Manners, “Global burden of disease estimates of </text>
<text top="683" left="123" width="233" height="9" font="0">depression — how reliable is the epidemiological evidence?”, </text>
<text top="683" left="358" width="118" height="9" font="20"><i>Journal of the Royal Society of </i></text>
<text top="693" left="123" width="34" height="9" font="20"><i>Medicine</i></text>
<text top="693" left="158" width="133" height="9" font="0">, vol. 104, No. 1 (2011), pp. 25-34. </text>
<text top="706" left="95" width="2" height="8" font="0"> </text>
<text top="704" left="114" width="6" height="5" font="18">78</text>
<text top="706" left="120" width="354" height="8" font="0">  David R. Williams, Naomi Priest and Norman Anderson, “Understanding associations among </text>
<text top="714" left="123" width="240" height="9" font="0">race, socioeconomic status, and health: patterns and prospects”, </text>
<text top="714" left="364" width="70" height="9" font="20"><i>Health Psychology</i></text>
<text top="714" left="435" width="38" height="9" font="0">, vol. 35,  </text>
<text top="725" left="123" width="124" height="9" font="0">No. 4 (April 2016), pp. 407-411. </text>
</page>
<page number="20" position="absolute" top="0" left="0" height="792" width="612">
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>20/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="73" left="123" width="367" height="11" font="3">biased  evidence  being  translated  into  practice  worldwide.  This  is  an  unacceptable </text>
<text top="85" left="123" width="367" height="11" font="3">tendency  and  must  be  addressed  by  States  and  international  organizations,  with  a </text>
<text top="97" left="123" width="368" height="11" font="3">view  to  ensuring  that  mental  health  policies  nationally  and  globally  are  driven  by </text>
<text top="109" left="123" width="367" height="11" font="3">non-biased  evidence  and  a  human  rights-based  approach.  The  obvious  crisis  in </text>
<text top="121" left="123" width="98" height="11" font="3">academic  psychiatry,</text>
<text top="121" left="222" width="6" height="6" font="18">79</text>
<text top="121" left="229" width="262" height="11" font="3">  influenced  by  a  doubtful  relationship  with  the </text>
<text top="133" left="123" width="367" height="11" font="3">pharmaceutical industry, has contributed to  what could be called the “corruption of </text>
<text top="145" left="123" width="367" height="11" font="3">knowledge”  in  mental  health  and  represents  a  warning  signal  not  only  to  mental </text>
<text top="157" left="123" width="299" height="11" font="3">health-care practice and research but to the health sector as a whole.   </text>
<text top="176" left="123" width="1" height="5" font="8"> </text>
<text top="182" left="123" width="1" height="5" font="8"> </text>
<text top="189" left="60" width="4" height="13" font="9"><b> </b></text>
<text top="186" left="99" width="239" height="16" font="9"><b>V.  Conclusions and recommendations </b></text>
<text top="203" left="123" width="1" height="5" font="8"> </text>
<text top="209" left="123" width="1" height="5" font="8"> </text>
<text top="216" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="214" left="99" width="94" height="13" font="10"><b>A.  Conclusions </b></text>
<text top="228" left="123" width="1" height="5" font="8"> </text>
<text top="234" left="123" width="1" height="5" font="8"> </text>
<text top="240" left="123" width="16" height="11" font="3">82. </text>
<text top="240" left="147" width="344" height="11" font="7"><b>Corruption  has  a  devastating  effect  on  good  governance,  the  rule  of  law </b></text>
<text top="252" left="123" width="367" height="11" font="7"><b>and equitable access to public goods and services. Corruption is a human rights </b></text>
<text top="264" left="123" width="367" height="11" font="7"><b>concern and it has a particularly damaging effect on the enjoyment of the right </b></text>
<text top="276" left="123" width="368" height="11" font="7"><b>to  health.  The  health  sector  is  especially  prone  to  corruption,  which  threatens </b></text>
<text top="288" left="123" width="242" height="11" font="7"><b>the sustainability of health-care systems worldwide.  </b></text>
<text top="306" left="123" width="16" height="11" font="3">83. </text>
<text top="306" left="147" width="343" height="11" font="7"><b>The  right  to  health  offers  a  valuable  normative  framework  and  a  legally </b></text>
<text top="318" left="123" width="367" height="11" font="7"><b>binding imperative to address corruption in and beyond the health sector. The </b></text>
<text top="330" left="123" width="368" height="11" font="7"><b>framework  embraces  the  principles  of  good  governance,  transparency, </b></text>
<text top="342" left="123" width="367" height="11" font="7"><b>accountability  and  participation.  The  right  to  health  is  closely  related  and </b></text>
<text top="354" left="123" width="367" height="11" font="7"><b>dependent  on  other  human  rights,  which  are  also  important  for  combating </b></text>
<text top="366" left="123" width="365" height="11" font="7"><b>corruption, including freedom of expression, which gives guarantees to whistle-</b></text>
<text top="378" left="123" width="41" height="11" font="7"><b>blowers. </b></text>
<text top="396" left="123" width="16" height="11" font="3">84. </text>
<text top="396" left="147" width="343" height="11" font="7"><b>All forms of corruption at all levels have a negative impact on realization </b></text>
<text top="408" left="123" width="367" height="11" font="7"><b>of  the  right  to  health.  Many  of  these  forms  originate  from  power  imbalances </b></text>
<text top="420" left="123" width="367" height="11" font="7"><b>and  asymmetries,  which  are  widely  prevalent  in  the  health  sector.  Such </b></text>
<text top="432" left="123" width="368" height="11" font="7"><b>asymmetries  are  perpetuated  by  non-transparent  decision-making  and </b></text>
<text top="444" left="123" width="357" height="11" font="7"><b>reinforce ineffective and harmful policymaking and health services provision.  </b></text>
<text top="462" left="123" width="16" height="11" font="3">85. </text>
<text top="462" left="147" width="343" height="11" font="7"><b>In  accordance  with  their  legal  obligations  under  international  human </b></text>
<text top="474" left="123" width="368" height="11" font="7"><b>rights law, as well as high-level political commitments made in the Sustainable </b></text>
<text top="486" left="123" width="367" height="11" font="7"><b>Development  Goals  to  address  corruption  and  develop  effective,  accountable </b></text>
<text top="498" left="123" width="367" height="11" font="7"><b>and  transparent  institutions  by  2030,  States  should  provide  leadership  to </b></text>
<text top="510" left="123" width="367" height="11" font="7"><b>confront  the  domestic  and  global  causes  of  corruption  and  its  impact  on  the </b></text>
<text top="522" left="123" width="367" height="11" font="7"><b>right  to  health  through  legal,  policy  and  programming  measures  in  the  health </b></text>
<text top="534" left="123" width="89" height="11" font="7"><b>and related sectors.</b></text>
<text top="534" left="213" width="5" height="11" font="3">  </text>
<text top="552" left="123" width="16" height="11" font="3">86. </text>
<text top="552" left="147" width="344" height="11" font="7"><b>Applying  a  human  rights-based  approach  to  health  and  related  policies </b></text>
<text top="564" left="123" width="367" height="11" font="7"><b>and avoiding selective approaches to human rights and the production and use </b></text>
<text top="576" left="123" width="367" height="11" font="7"><b>of  evidence  in  the  realization  of  the  right  to  health  are  the  most  effective </b></text>
<text top="588" left="123" width="170" height="11" font="7"><b>measures for combating corruption.  </b></text>
<text top="606" left="123" width="1" height="5" font="8"> </text>
<text top="612" left="123" width="1" height="5" font="8"> </text>
<text top="620" left="60" width="3" height="11" font="10"><b> </b></text>
<text top="617" left="99" width="128" height="13" font="10"><b>B.  Recommendations </b></text>
<text top="632" left="123" width="1" height="5" font="8"> </text>
<text top="638" left="123" width="1" height="5" font="8"> </text>
<text top="643" left="123" width="16" height="11" font="3">87. </text>
<text top="643" left="147" width="186" height="11" font="7"><b>The Special Rapporteur urges States to: </b></text>
<text top="663" left="123" width="2" height="9" font="3"> </text>
<text top="661" left="147" width="14" height="11" font="3">(a) </text>
<text top="661" left="171" width="320" height="11" font="7"><b>Implement the United Nations Convention against Corruption and to </b></text>
<text top="674" left="123" width="367" height="11" font="7"><b>explicitly  criminalize  the  corrupt  acts  identified  in  that  treaty  and  which  are </b></text>
<text top="686" left="123" width="158" height="11" font="7"><b>also prevalent in the health sector;</b></text>
<text top="688" left="282" width="2" height="9" font="3"> </text>
<text top="702" left="100" width="74" height="7" font="19"><b>__________________ </b></text>
<text top="716" left="95" width="2" height="8" font="0"> </text>
<text top="714" left="114" width="6" height="5" font="18">79</text>
<text top="716" left="120" width="349" height="8" font="0">  Arthur Kleinman, “Rebalancing academic psychiatry: why it needs to happen  — and soon”, </text>
<text top="714" left="469" width="16" height="9" font="20"><i>The </i></text>
<text top="725" left="123" width="108" height="9" font="20"><i>British Journal of Psychiatry</i></text>
<text top="725" left="232" width="183" height="9" font="0">, vol. 201, No. 6 (December 2012), pp. 421-422. </text>
</page>
<page number="21" position="absolute" top="0" left="0" height="792" width="612">
<text top="57" left="60" width="2" height="8" font="0"> </text>
<text top="53" left="521" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="532" width="22" height="8" font="13"><b>21/22 </b></text>
<text top="749" left="60" width="29" height="6" font="14">17-11954 </text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="75" left="123" width="2" height="9" font="3"> </text>
<text top="73" left="147" width="15" height="11" font="3">(b) </text>
<text top="73" left="171" width="320" height="11" font="7"><b>Ensure  the  integration  of  the  right  to  health  as  a  standard  in </b></text>
<text top="85" left="123" width="328" height="11" font="7"><b>anti-corruption laws and policies aimed at regulating the health sector; </b></text>
<text top="105" left="123" width="2" height="9" font="3"> </text>
<text top="103" left="147" width="14" height="11" font="3">(c) </text>
<text top="103" left="171" width="320" height="11" font="7"><b>Provide  for  comprehensive  whistle-blower  protection  for  those </b></text>
<text top="115" left="123" width="367" height="11" font="7"><b>reporting  corruption  offences  in  the  health  sector  and  beyond,  which  includes </b></text>
<text top="127" left="123" width="291" height="11" font="7"><b>guaranteeing the anonymity and protection of whistle-blowers; </b></text>
<text top="147" left="123" width="2" height="9" font="3"> </text>
<text top="145" left="147" width="15" height="11" font="3">(d) </text>
<text top="145" left="171" width="320" height="11" font="7"><b>Progressively  build  resilient  health  systems,  with  a  special  focus  on </b></text>
<text top="157" left="123" width="367" height="11" font="7"><b>health  promotion  and  primary  care,  so  as  to  root  out  the  problem  of  systemic </b></text>
<text top="169" left="123" width="194" height="11" font="7"><b>incentives for corruption in health sector; </b></text>
<text top="189" left="123" width="2" height="9" font="3"> </text>
<text top="187" left="147" width="14" height="11" font="3">(e) </text>
<text top="187" left="171" width="320" height="11" font="7"><b>When elements of a health sector are decentralized or handed over to </b></text>
<text top="199" left="123" width="368" height="11" font="7"><b>the  private  sector,  to  ensure  that  there  are  sufficient  checks  and  balances  to </b></text>
<text top="211" left="123" width="367" height="11" font="7"><b>ensure that this transition addresses corruption and, at the least, does not lead </b></text>
<text top="223" left="123" width="367" height="11" font="7"><b>to  more  corruption.  There  must  be  adequate  oversight,  transparency  and </b></text>
<text top="235" left="123" width="261" height="11" font="7"><b>monitoring of private sector and decentralized provision;</b></text>
<text top="238" left="386" width="2" height="9" font="3"> </text>
<text top="255" left="123" width="2" height="9" font="3"> </text>
<text top="253" left="147" width="13" height="11" font="3">(f) </text>
<text top="253" left="171" width="320" height="11" font="7"><b>Raise  awareness  among  the  actors  in  the  health  sector,  including </b></text>
<text top="265" left="123" width="367" height="11" font="7"><b>health-care  providers,  insurers  and  the  providers  of  medicines  and  medical </b></text>
<text top="277" left="123" width="367" height="11" font="7"><b>equipment  about  the  harmful  effects  of  corruption  on  the  right  to  health  and </b></text>
<text top="289" left="123" width="253" height="11" font="7"><b>insist on their responsibilities under the right to health;</b></text>
<text top="292" left="377" width="2" height="9" font="3"> </text>
<text top="309" left="123" width="2" height="9" font="3"> </text>
<text top="307" left="147" width="15" height="11" font="3">(g) </text>
<text top="307" left="171" width="320" height="11" font="7"><b>Raise  awareness  among  the  general  population  about  the  negative </b></text>
<text top="319" left="123" width="367" height="11" font="7"><b>impact of all forms of corruption in the health sector on individual and societal </b></text>
<text top="331" left="123" width="367" height="11" font="7"><b>health  and  well-being.  National  human  rights  institutions  can  play  a  role  in </b></text>
<text top="343" left="123" width="365" height="11" font="7"><b>such  awareness-raising  and  this  may  include  the  establishment  of  corruption-</b></text>
<text top="355" left="123" width="88" height="11" font="7"><b>reporting hotlines; </b></text>
<text top="374" left="123" width="1" height="5" font="8"> </text>
<text top="381" left="60" width="3" height="9" font="7"><b> </b></text>
<text top="381" left="111" width="3" height="9" font="7"><b> </b></text>
<text top="379" left="123" width="217" height="11" font="7"><b>Participation, transparency and accountability </b></text>
<text top="392" left="123" width="1" height="5" font="8"> </text>
<text top="399" left="123" width="2" height="9" font="3"> </text>
<text top="397" left="147" width="15" height="11" font="3">(h) </text>
<text top="397" left="171" width="320" height="11" font="7"><b>Guarantee  the  right  to  participation  of  the  population  in  all  actions </b></text>
<text top="409" left="123" width="368" height="11" font="7"><b>aimed  at  combating  corruption  in  health,  such  as  through  the  disclosure  of </b></text>
<text top="421" left="123" width="367" height="11" font="7"><b>important  health-related  information,  as  well  as  in  the  design  and  delivery  of </b></text>
<text top="434" left="123" width="95" height="11" font="7"><b>health programmes; </b></text>
<text top="453" left="123" width="2" height="9" font="3"> </text>
<text top="451" left="147" width="13" height="11" font="3">(i) </text>
<text top="451" left="171" width="320" height="11" font="7"><b>Engage  a  variety  of  stakeholders,  such  as  community  organizations, </b></text>
<text top="464" left="123" width="368" height="11" font="7"><b>professional  organizations  and  civil  society  organizations,  including  those </b></text>
<text top="476" left="123" width="367" height="11" font="7"><b>representing  groups  in  vulnerable  situations,  in  determining  the  allocation  of </b></text>
<text top="488" left="123" width="367" height="11" font="7"><b>funding, as well as in monitoring budget expenditure at the national, local and </b></text>
<text top="500" left="123" width="90" height="11" font="7"><b>institutional levels; </b></text>
<text top="519" left="123" width="2" height="9" font="3"> </text>
<text top="517" left="147" width="13" height="11" font="3">(j) </text>
<text top="517" left="171" width="320" height="11" font="7"><b>Ensure  monitoring  and  accountability  in  the  health  sector  and </b></text>
<text top="530" left="123" width="368" height="11" font="7"><b>related  sectors  through  the  establishment  of  well-resourced  and  independent </b></text>
<text top="542" left="123" width="367" height="11" font="7"><b>anti-corruption  and  fraud  agencies,  as  well  as  accessible  and  effective </b></text>
<text top="554" left="123" width="367" height="11" font="7"><b>accountability  procedures  for  health  system  users  who  encounter  corrupt </b></text>
<text top="566" left="123" width="44" height="11" font="7"><b>practices;</b></text>
<text top="568" left="168" width="2" height="9" font="3"> </text>
<text top="585" left="123" width="2" height="9" font="3"> </text>
<text top="583" left="147" width="15" height="11" font="3">(k) </text>
<text top="583" left="171" width="320" height="11" font="7"><b>Ensure  judicial  and  other  forms  of  review  of  violations  of </b></text>
<text top="596" left="123" width="367" height="11" font="7"><b>anti-corruption  legislation; and  effective  remedies where  corruption leads to  a </b></text>
<text top="608" left="123" width="147" height="11" font="7"><b>violation of the right to health;  </b></text>
<text top="626" left="123" width="1" height="5" font="8"> </text>
<text top="633" left="60" width="3" height="9" font="7"><b> </b></text>
<text top="633" left="111" width="3" height="9" font="7"><b> </b></text>
<text top="631" left="123" width="167" height="11" font="7"><b>Corruption in health-care provision </b></text>
<text top="644" left="123" width="1" height="5" font="8"> </text>
<text top="651" left="123" width="2" height="9" font="3"> </text>
<text top="649" left="147" width="13" height="11" font="3">(l) </text>
<text top="649" left="171" width="320" height="11" font="7"><b>Address  petty  corruption  by  health  professionals  by  guaranteeing </b></text>
<text top="662" left="123" width="367" height="11" font="7"><b>decent living  wages  and working conditions,  job security and  reward for good </b></text>
<text top="674" left="123" width="124" height="11" font="7"><b>performance and conduct; </b></text>
<text top="693" left="123" width="2" height="9" font="3"> </text>
<text top="691" left="147" width="18" height="11" font="3">(m) </text>
<text top="691" left="171" width="320" height="11" font="7"><b>Prevent  misuse  of  dual  practices  whereby  health-care  providers </b></text>
<text top="704" left="123" width="368" height="11" font="7"><b>inappropriately  refer  patients  to  their  own  private  practices;  and  take </b></text>
<text top="716" left="123" width="268" height="11" font="7"><b>measures to reduce theft and improper billing in hospitals;</b></text>
<text top="718" left="393" width="2" height="9" font="3"> </text>
</page>
<page number="22" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="23" size="10" family="Times New Roman,Bold" color="#0000ff"/>
<text top="53" left="60" width="34" height="8" font="13"><b>A/72/137 </b></text>
<text top="57" left="302" width="2" height="8" font="0"> </text>
<text top="67" left="60" width="2" height="8" font="0"> </text>
<text top="749" left="525" width="29" height="6" font="14">17-11954 </text>
<text top="749" left="60" width="22" height="8" font="13"><b>22/22 </b></text>
<text top="759" left="60" width="2" height="8" font="13"><b> </b></text>
<text top="75" left="123" width="2" height="9" font="3"> </text>
<text top="73" left="147" width="15" height="11" font="3">(n) </text>
<text top="73" left="171" width="320" height="11" font="7"><b>Create  awareness  among  health-care  providers  that  preferential </b></text>
<text top="85" left="123" width="367" height="11" font="7"><b>treatment of well-connected individuals is unethical and at odds with the main </b></text>
<text top="97" left="123" width="217" height="11" font="7"><b>principles for realization of the right to health; </b></text>
<text top="117" left="123" width="2" height="9" font="3"> </text>
<text top="115" left="147" width="15" height="11" font="3">(o) </text>
<text top="115" left="171" width="320" height="11" font="7"><b>Develop  non-biased  and  evidence-based  treatment  guidelines  to </b></text>
<text top="127" left="123" width="167" height="11" font="7"><b>reduce opportunities for corruption;</b></text>
<text top="130" left="291" width="2" height="9" font="3"> </text>
<text top="147" left="123" width="2" height="9" font="3"> </text>
<text top="145" left="147" width="15" height="11" font="3">(p) </text>
<text top="145" left="171" width="320" height="11" font="7"><b>Create  awareness,  for  example  through  the  development  of  ethical </b></text>
<text top="157" left="123" width="368" height="11" font="7"><b>guidelines,  among  health-care  providers  that  they  should  remain  independent </b></text>
<text top="169" left="123" width="367" height="11" font="7"><b>from outside organizations and avoid conflicts of interest with the best interests </b></text>
<text top="181" left="123" width="79" height="11" font="7"><b>of their patients; </b></text>
<text top="201" left="123" width="2" height="9" font="3"> </text>
<text top="199" left="147" width="15" height="11" font="3">(q) </text>
<text top="199" left="171" width="320" height="11" font="7"><b>Create  awareness  among  health  system  users  of  their  rights  as  well </b></text>
<text top="211" left="123" width="193" height="11" font="7"><b>as identifying and reporting corrupt acts; </b></text>
<text top="231" left="123" width="2" height="9" font="3"> </text>
<text top="229" left="147" width="13" height="11" font="3">(r) </text>
<text top="229" left="171" width="320" height="11" font="7"><b>Support  initiatives  that  prevent  excessive  and  unnecessary  use  of </b></text>
<text top="241" left="123" width="367" height="11" font="7"><b>diagnostic  and  treatment  interventions  and  involve  users  of  services  in  shared </b></text>
<text top="253" left="123" width="179" height="11" font="7"><b>decision-making with medical doctors. </b></text>
<text top="271" left="123" width="16" height="11" font="3">88. </text>
<text top="271" left="147" width="305" height="11" font="7"><b>The Special Rapporteur also urges other relevant stakeholders to: </b></text>
<text top="291" left="123" width="2" height="9" font="3"> </text>
<text top="289" left="147" width="14" height="11" font="3">(a) </text>
<text top="289" left="171" width="320" height="11" font="7"><b>Take  into  account  the Human  Rights  Guidelines for Pharmaceutical </b></text>
<text top="301" left="123" width="212" height="11" font="7"><b>Companies in relation to Access to Medicines <a href="https://undocs.org/A/63/263">(</a></b></text>
<text top="301" left="336" width="40" height="11" font="23"><a href="https://undocs.org/A/63/263"><b>A/63/263</b></a></text>
<text top="301" left="377" width="43" height="11" font="7"><a href="https://undocs.org/A/63/263"><b>,</b></a><b> annex); </b></text>
<text top="321" left="123" width="2" height="9" font="3"> </text>
<text top="319" left="147" width="15" height="11" font="3">(b) </text>
<text top="319" left="171" width="320" height="11" font="7"><b>Address, through legal, policy and other measures, corrupt practices </b></text>
<text top="331" left="123" width="367" height="11" font="7"><b>taking  place  in  all  stages  of  the  pharmaceutical  value  chain,  including  during </b></text>
<text top="343" left="123" width="367" height="11" font="7"><b>research  and  development,  manufacturing,  registration,  distribution, </b></text>
<text top="355" left="123" width="192" height="11" font="7"><b>procurement and marketing of medicines;</b></text>
<text top="355" left="316" width="5" height="11" font="3">  </text>
<text top="375" left="123" width="2" height="9" font="3"> </text>
<text top="373" left="147" width="14" height="11" font="3">(c) </text>
<text top="373" left="171" width="320" height="11" font="7"><b>Strengthen  measures  to  address  corruption  and  unethical  practices </b></text>
<text top="385" left="123" width="367" height="11" font="7"><b>in  the  process  of  generation  of  knowledge  through  research,  dissemination  of </b></text>
<text top="397" left="123" width="367" height="11" font="7"><b>such  knowledge  through  medical  education  and  the  development  of  guidelines </b></text>
<text top="409" left="123" width="234" height="11" font="7"><b>for diagnostics and treatment of health conditions; </b></text>
<text top="429" left="123" width="2" height="9" font="3"> </text>
<text top="427" left="147" width="15" height="11" font="3">(d) </text>
<text top="427" left="171" width="320" height="11" font="7"><b>Strengthen  those  elements  in  the  medical  education  curriculum  of </b></text>
<text top="440" left="123" width="367" height="11" font="7"><b>future  medical  doctors  that  strengthen  their  knowledge  and  skills  in  order  to </b></text>
<text top="452" left="123" width="367" height="11" font="7"><b>prevent  them  from  becoming  involved  in  corrupt  acts,  unethical  behaviour, </b></text>
<text top="464" left="123" width="367" height="11" font="7"><b>reliance  on  excessive  and  unnecessary  medical  interventions,  disease </b></text>
<text top="476" left="123" width="368" height="11" font="7"><b>mongering, favouritism, informal payments and other practices that are either </b></text>
<text top="488" left="123" width="199" height="11" font="7"><b>corrupt or increase the risk of corruption;  </b></text>
<text top="507" left="123" width="2" height="9" font="3"> </text>
<text top="505" left="147" width="14" height="11" font="3">(e) </text>
<text top="505" left="171" width="320" height="11" font="7"><b>Address  the  production  and  dissemination  of  biased  outcomes  of </b></text>
<text top="518" left="123" width="367" height="11" font="7"><b>research  in  psychiatry  and  prevent,  through  transparent  changes  in  medical </b></text>
<text top="530" left="123" width="367" height="11" font="7"><b>education,  research  and  practice,  institutional  corruption  in  psychiatry  and </b></text>
<text top="542" left="123" width="88" height="11" font="7"><b>mental health care;</b></text>
<text top="544" left="212" width="2" height="9" font="3"> </text>
<text top="561" left="123" width="2" height="9" font="3"> </text>
<text top="559" left="147" width="13" height="11" font="3">(f) </text>
<text top="559" left="171" width="320" height="11" font="7"><b>Enhance transparency and avoid misusing the principle of academic </b></text>
<text top="572" left="123" width="367" height="11" font="7"><b>autonomy  when  investments  in  health  and  health  care  are  addressed,  so  that </b></text>
<text top="584" left="123" width="367" height="11" font="7"><b>the integrity of academic medicine and its commitment to the realization of the </b></text>
<text top="596" left="123" width="154" height="11" font="7"><b>right to health is not undermined.</b></text>
<text top="598" left="278" width="2" height="9" font="3"> </text>
<text top="615" left="123" width="2" height="9" font="3"> </text>
</page>
</pdf2xml>
